title: 99/520/CE: Decisão da Comissão, de 9 de Julho de 1999, que altera a Decisão 98/589/CE da Comissão relativa à prorrogação do prazo previsto para a aplicação de marcas auriculares a determinados animais bovinos do efectivo espanhol [notificada com o número C(1999) 2039] (Texto relevante para efeitos do EEE)

eurovoc_concepts: Spain cattle database labelling livestock trademark

text: L 199/72 PT Jornal Oficial das Comunidades Europeias 30. 7. 1999 COMISSÃO DECISÃO DA COMISSÃO de 9 de Julho de 1999 que altera a Decisão 98/589/CE da Comissão relativa à prorrogação do prazo previsto para a aplicação de marcas auriculares a determinados animais bovinos do efectivo espanhol [notificada com o número C(1999) 2039] (Texto relevante para efeitos do EEE) (1999/520/CE) A COMISSÃO DAS COMUNIDADES EUROPEIAS, (4) Considerando que as medidas previstas na presente decisão estão em conformidade com o parecer do Comité do Fundo Europeu de Orientação e de Garantia Agrícola, ADOPTOU A PRESENTE DECISÃO: Artigo 1. o No anexo da Decisão 98/589/CE da Comissão, na coluna «Comarca», no respeitante à «Provincia Palencia», as referências «El Cerrato, Campose Saldaña-Valdavia» são substituídas pela referência «Toda la Provincia». Artigo 2. o Os Estados-Membros são os destinatários da presente decisão. Feito em Bruxelas, em 9 de Julho de 1999. Pela Comissão Franz FISCHLER Membro da Comissão Tendo em conta o Tratado que institui a Comunidade Europeia, Tendo em conta o Regulamento (CE) n. o 820/97 do Conselho, de 21 de Abril de 1997, que estabelece um regime de identifi- cação e registo de bovinos e relativo à rotulagem da carne de bovino e dos produtos à base de carne de bovino (1), e, nomea- damente, o n. o 2 do seu artigo 4. o, Tendo em conta o pedido apresentado pela Espanha, (1) (2) (3) Considerando que a Decisão 98/589/CE da Comissão (2) concedeu ao Reino de Espanha, devido a dificuldades de ordem prática, o prolongamento, até seis meses, do período máximo previsto para a aplicação de marcas auriculares a determinados bovinos; Considerando que, na sequência de um pedido apresen- tado pelas autoridades espanholas, deve ser alterado o anexo da referida decisão, a fim de incluir a totalidade da «Comarcas» província de Palencia em vez das mencionadas originariamente no anexo da Decisão 98/ /589/CE da Comissão; três Considerando que a alteração é justificada dado que os animais nascidos nessa província preenchem as condi- ções estipuladas na decisão; (1) JO L 117 de 7. 5. 1997, p. 1. (2) JO L 283 de 21. 10. 1998, p. 19


title: 1999/449/EC: Commission Decision of 9 July 1999 on protective measures with regard to contamination by dioxins of certain products of animal origin intended for human or animal consumption (notified under document number C(1999) 2110) (Text with EEA relevance)

eurovoc_concepts:
Belgium
animal nutrition
animal product
health control
human nutrition
toxic substance

formats: html pdf print

text: L 175/70 EN Official Journal of the European Communities 10. 7. 1999 COMMISSION DECISION of 9 July 1999 on protective measures with regard to contamination by dioxins of certain products of animal origin intended for human or animal consumption (notified under document number C(1999) 2110) (Text with EEA relevance) (1999/449/EC) THE COMMISSION OF THE EUROPEAN COMMUNITIES, (3) Having regard to the Treaty establishing the European Community, Having regard to Council Directive 89/662/EEC of 11 December 1989 concerning veterinary checks in intra- Community trade with a view to the completion of the internal market (1), as last amended by Directive 92/118/EEC (2), and in particular Article 9(4) thereof, Having regard to Council Directive 90/425/EEC of 26 June 1990 concerning veterinary and zootechnical checks applicable in intra-Community trade in certain live animal and products with a view to the completion of the internal market (3), as last amended by Directive 92/118/EEC, and in particular Article 10(4) thereof, Whereas: (1) (2) Commission Decision 1999/363/EC of 3 June 1999 on protective measures with regards to contamination by dioxins of certain animal products intended for human or animal consumption (4), as last amended by Decision 1999/419/EC (5), and Commission Decision 1999/ 389/EC of 11 June 1999 on protective measures with regards to contamination by dioxins of products intended for human consumption derived from bovine and revoking Decision 1999/ animals 368/EC (6), as last amended by Decision 1999/419/EC, have each been substantially amended. Since further amendments are to be made, they should be recast in a single decision in the interests of clarity and rationalisa- tion. and pigs On 27 May 1999, the Belgian authorities informed the Commission of a case of heavy contamination of compound feedingstuffs with dioxins. Those feeding- stuffs had been distributed to a considerable number of domestic fowl farms in Belgium (some 25 %) from 15 January 1999 onwards. (1) OJ L 395, 30. 12. 1989, p. 13. (2) OJ L 62, 15. 3. 1993, p. 49. (3) OJ L 224, 18. 8. 1990, p. 20. (4) OJ L 141, 4. 6. 1999, p. 24. (5) OJ L 159, 25. 6. 1999, p. 60. (6) OJ L 147, 12. 6. 1999, p. 26. (4) (5) (6) From 26 May 1999, the Belgian authorities placed restrictions on all the domestic fowl holdings which had received those feedingstuffs. The Belgian authorities prohibited the slaughter of poultry from 1 June 1999. Products intended for human or animal consumption derived from animals reared in those farms before that date may still be on the market. On 2 June 1999, the Belgian authorities informed the Commission that they had placed restrictions on some 500 pig holdings which may have received contami- nated feedingstuffs. On 3 June 1999, they also informed the Commission that contaminated feedingstuffs had been distributed to a number of bovine holdings as well. The Belgian authorities have taken actions on pigs and bovine animals and derived products similar to those applied in the case of poultry and, in particular, they have prohibited the slaughter of bovine animals and pigs from 3 June 1999. It appears that those feedingstuffs, live animals which had been fed therewith and products derived from those animals have been traded to other Member States and third countries. Other animal species may have been fed with those contaminated feedingstuffs. Investigation of the responsibility for this contamination is continuing. The Community inspection in Belgium on 8 to 11 June 1999 concluded that, on the basis of the available results of analyses, a massive contamination occurred over a limited time, rather than a recurring problem. In the light of the foregoing, it is necessary to take measures to protect the health of consumers. The meas- ures should apply to domestic fowl, pigs and bovine animals reared in Belgium from 15 January onwards and to products derived therefrom. The measures should not apply to products derived from animals which have not been reared in holdings placed under restriction by the Belgian authorities or which have been shown by analyses not to be contaminated by dioxins. Provision should be made for those products to be destroyed in a manner that ensures that they cannot enter the human food or animal feed chains. It is not yet appropriate to set an end-date for the application of the measures. In the measures order to prevent deflections of trade, 10. 7. 1999 EN Official Journal of the European Communities L 175/71 should also apply to exports to third countries. All relevant information should be supplied to the Commis- sion, the Member States and third countries, where appropriate by means of the rapid alert system set up by Council Directive 92/59/EEC of 29 June 1992 on intra- general product safety (1). For the purposes of community trade and exports to third countries, a system of certificates should be established for consign- ments of Belgian origin. It is necessary that Belgium and Member States which received products derived from animals which have been reared in holdings placed under restriction establish a monitoring plan to evaluate the presence of contamination of dioxins/polychlori- nated biphenyls (PCBs) in products of animal origin. Inspections should be carried out by the Commission in order to verify the implementation of this Decision. (10) to consider The body of toxicological and epidemiological evidence available today has led the International Agency for Research on Cancer (IARC) of the World Health Organ- isation (WHO) tetrachlordibenzo-dioxin (TCDD) a class 1 carcinogen (the highest class in the IARC ranking). The WHO has recommended that a tolerable daily intake (TDI) of 14 pg/kg bw/day be respected for dioxins. No limits for dioxin contamina- tion have been set for individual commodities and food products. Data on background levels of contamination do exist. In the absence of limits for dioxins at inter- national, Community or national level, the data on back- ground levels should be used as references. The analysis of dioxins requires sophisticated methods which are available only in a limited number of laboratories in the Member States. (7) (8) It appears to be difficult to trace back the exact origin of certain Belgian products and, in particular, products derived from domestic fowl produced between 15 January 1999 and 1 June 1999 and products derived from bovine animals and pigs produced between 15 January 1999 and 3 June 1999. The Belgian authorities are prepared to accept the return of those products from Member States in application of Article 7 of Directive 89/662/EC. It is necessary to lay down strict and specific rules on the procedure to be followed when the prod- ucts are returned to Belgium in order to ensure that they cannot re-enter the human food or animal feed chains before they are submitted to appropriate checks to verify the Belgian authorities their safety. Considering that informed the Commission of difficulties in using the ANIMO network set up by Council Directive 91/ 398/EC (2), it is appropriate to inform directly by means of telefax the Belgian central competent authority of the return of the products. Article 15 of Council Directive 97/78/EC of 18 December 1997 laying down the principles governing the organisation of veterinary checks on products entering the Community from third countries (3) estab- lishes specific rules for the re-importation of consign- ments of products of Community origin which have been refused by a third country. It is necessary to estab- lish that products returned from third countries to Belgium cannot re-enter the human food or animal feed chains before they are submitted to the appropriate checks to verify their safety. (11) On 11 June 1999 a Commission working group on PCBs as markers for dioxin contamination concluded that the levels of seven persistent PCBs in eggs and poultry-meat products can be used reliably as a surro- gate for dioxins. Furthermore, it concluded that an action level of 200 ng PCB (sum of 7 congeners)/g fat be used for poultry products. On 16 June 1999 the Scientific Committee for Food adopted an opinion on dioxins in milk derived from cattle fed on contaminated feed in Belgium. In its opinion, the Committee stressed the need to analyse milk samples from all dairy farms placed under restriction by the Belgian authority, indi- vidually, at least for PCBs, using an adequate limit of quantification, as an indicator for a possible dioxin contamination, above background. For this purpose, the Committee recommended that an action level of 100 ng PCB (sum of 7 congeners)/g fat be used for milk and milk products. This action level should be applied for screening purpose for raw milk from the individual farms in question, for bulked milk from dairies, and for any milk products manufactured since the date of known contamination of animal feed. Where the levels above 100 ng PCB/g fat are found, this should trigger analysis for dioxins. The Committee and the Commis- sion working group stressed those action levels are only intended to apply in the context of the present particular situation in Belgium and should not be taken as an endorsement of a permanent limit for PCBs in the prod- ucts concerned. (9) Council Directive 1999/29/EEC of 22 April 1999 on the undesirable substances and products in animal nutri- tion (4) provides that feed materials may only be put into circulation in the Community if they are sound, genuine and of merchantable quality, (12) (1) OJ L 228, 11. 8. 1992, p. 24. (2) OJ L 221, 9. 8. 1991, p. 30. (3) OJ L 24, 30. 1. 1998, p. 9. (4) OJ L 115, 4. 5. 1999, p. 32. In compliance with the above scientific opinion of 16 June 1999, the Belgian authorities carried out individual analyses of raw milk from all the 234 individual farms placed under restriction, bulked milk from dairies, and milk products manufactured since the date of known contamination of animal feed. The results indicated that, with the exception of 9 farms, the current and past products from 225 farms have no health significance for L 175/72 EN Official Journal of the European Communities 10. 7. 1999 it is appro- the consumers. Considering these results, priate to remove milk and milk products from the scope of Decision 1999/389/EC. However, in accordance with the recommendation of the Scientific Committee for Food, it is necessary to maintain under restriction the products from dairy farms where the action level for milk is exceeded until the results of analysis demonstrate that the milk is not contaminated with dioxins. (13) On 28 and 29 June 1999 a Commission working group on the PCB/dioxin contamination of the Belgian food supply considered the adequacy of a threshold of 2 % of fat below which the foodstuffs subject to the provision of Decisions 1999/363/EC and 1999/389/EC would be exempted from the scope of those Decisions. That working group concluded that, in the light of the above- mentioned opinion of the Scientific Food Committee and considering the data available so far on PCBs and dioxins in Belgian products, it is reasonable to assume, in the case of egg products containing less than 10 % of egg fat it is unlikely that their presence in amounts below 2 % increases PCB and dioxins intake significantly above background levels. (14) Article 9(4) of Directive 89/662/EEC and Article 10(4) of Directive 90/425/EEC authorise the Commission to adopt safeguard measures for animals and products referred to in Article 1 and, if the situation so requires, products or products derived from those products. Therefore, these measures can also cover incidentally other products which are not included in Annex I to the Treaty. The situation as regards the dioxin contamina- tion justifies such measures. (15) Article 3 of Decision 1999/363/EC and Article 3 of Decision 1999/389/EC established measures for Member States which received products of Belgian origin covered by those Decisions. Discussions with Member States have revealed that there are problems of implementation and interpretation of those provisions and they should therefore be clarified. (16) The measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Committee, HAS ADOPTED THIS DECISION: Article 1 below which are intended for human or animal consumption and are derived from domestic fowl reared in Belgium between 15 January 1999 and 1 June 1999 or from pigs and bovine animals reared in Belgium between 15 January 1999 and 3 June 1999: — fresh poultrymeat, as defined by Council Directive 71/118/EEC (1); — fresh meat, as defined by Council Directive 64/433/EEC (2); — mechanically recovered meat; — minced meat and meat preparation, as defined by Council Directive 94/65/EC (3); — meat products and other products of animal origin as defined by Council Directive 77/99/EEC (4); — products intended for human consumption which contain other products of bovine, porcine or poultry origin as defined by Council Directive 77/99/EEC, which contain more that 2 % of animal fat, with the exclusion of milk fat, — eggs; — egg products, as defined by Council Directive 89/437/EEC (5), with the exclusion of egg white; — products intended for human consumption which contain more than 2 % of eggs or more than 2 % of egg products containing more than 10 % of egg fat; — rendered fats, as referred to in Directive 92/118/EEC; — processed animal proteins, as referred to in Directive 92/118/EEC; — raw material for the manufacture of animal feeding- stuffs, as referred to by Council Directive 92/118/EC, — compound feedingstuffs and pre-mixtures. B. Belgium shall maintain under restriction raw milk collected after 12 June 1999, and heat treated milk and milk based products derived therefrom, from holding which, whenever tested, did not comply with the limits set in Annex A, until such time as the result of analysis demonstrate that the milk is not contaminated with dioxins. The prohibition set out in paragraph 1A. shall not apply 2. where: (a) the products are not derived from animals reared in hold- ings put under restriction by the Belgian authorities; or (b) the results of analysis demonstrate that the products are not contaminated with dioxins or, that they do not exceed the levels for PCBs set out in Annex A. 3. Belgium shall prohibit the placing on the market, the trade and the export to third countries of live domestic fowls reared between 15 January 1999 and l June 1999 or hatching eggs laid by those domestic fowls during that period and of pigs and bovine animals reared between 15 January 1999 and 3 June 1999, unless the animals have not been reared and the eggs have not been produced in holdings placed under restric- tions by the Belgian authorities. 1. A. Belgium shall prohibit the placing on the market, including distribution to the final consumer, the trade and the export to third countries, of the products listed (1) OJ L 55, 8. 3. 1971, p. 23. (2) OJ L 121, 29. 7. 1964, p. 2012/64. (3) OJ L 368, 31. 12. 1994, p. 10. (4) OJ L 26, 31. 1. 1977, p. 85. (5) OJ L 212, 22. 7. 1989, p. 87. 10. 7. 1999 EN Official Journal of the European Communities L 175/73 Belgium shall ensure that all the products referred to in 4. paragraph 1 which do not fulfil the conditions laid down in paragraph 2 are destroyed by means approved by the competent authorities in a manner that ensures that they cannot enter the human food or animal feed chain. 5. Belgium shall inform immediately the Commission and the Member States, if appropriate by means of the rapid alert system under Directive 92/59/EEC, and third countries which have received the live animals, hatching eggs referred to in paragraph 3 or products covered by paragraph 4 of this Article; 6. Belgium shall investigate: (a) possible remaining stocks of contaminated feedingstuffs, and (b) possible distribution of contaminated feedingstuffs with dioxins to other farm animals and to other Member States and third countries. inform without delay the Commission and other It shall Member States and third countries concerned of the results of such investigations. Belgium shall monitor the level of dioxins in Belgian 7. products of animal origin. For this purpose, Belgium shall monitoring plan to the Commission. submit without delay a Belgium shall keep the Commission and the Member its investigation into the 8. States informed of the results of source of the contamination of feedingstuffs by dioxins. State of dispatch and in the official language of the Member State of destination and they shall consist of a single sheet. Article 3 Member States which have received feedingstuffs suspected of being contaminated with dioxins, live animals or hatching eggs which have been reared or produced in holdings placed under restrictions by the Belgian authorities and/or products of Belgian origin covered by Article 1(4), shall immediately: (a) carry out an investigation into the distribution of those feedingstuffs and into possible remaining stocks; (b) trace and place restrictions on those animals and hatching eggs and products arising therefrom; (c) trace back all products derived from animals fed with those feedingstuffs, and products listed in Article 1(1)(A) destined for human or animal consumption which contain those products; (d) trace back all products of Belgian origin to which this Decision applies, and products listed in Article 1(1)(A) which are destined for human or animal consumption containing those products of Belgian origin; (e) ensure that the products referred to in points (a) to (d) are destroyed by a means approved by the competent authority in a manner that ensures that they cannot enter the human food or animal feed chain, unless it can be proved they are not contaminated with dioxins or, that they do not exceed the levels for PCB set out in Annex A; (f) inform immediately the Commission and the Member States, if appropriate by means of the rapid alert system under Directive 92/59/EEC, and third countries concerned on the findings of their investigation and on the eventual actions taken; Article 2 (g) monitor the level of dioxins in products of animal origin. For the purpose of infra-Community trade and export to 1. third countries, in addition to the appropriate commercial document or to the official certificate, each consignment of products of Belgian origin listed in Article 1(1)(A) must be accompanied by an official certificate signed by the Belgian competent authority as laid down in Annex B. 2. For the purpose of infra-Community trade and export to third countries, the appropriate health certificate accompanying each consignment of live domestic fowl and hatching eggs derived therefrom, of Belgian origin must be accompanied by an official declaration signed by the Belgian competent authority as laid down in Annex C. 3. For the purpose of infra-Community trade and export to third countries, the appropriate health certificate accompanying each consignment of bovine animals and pigs of Belgian origin must be accompanied by an official declaration signed by the Belgian competent authority as laid down in Annex D. The official 4. certificate and the official declarations referred to in paragraphs 1, 2 and 3 shall be drawn up on the date of loading in the language or languages of the Member For this purpose, the Member States concerned shall without delay submit a monitoring plan to the Commission. Article 4 On request of a Member State or of a third country which has received live animals, hatching eggs or products listed in Article 1(1)(A) and Article 1(3) before 12 June 1999, Belgium, where it has such information, shall provide a declaration on the status of the holding of origin in accordance with the model set out in Annex E. Article 5 By way of derogation from Article 3(e), 1. in accordance with Article 7 of Directive 89/662/EEC, Member States may return products of Belgian origin to which Article 1(1)(A) applies to Belgium in cases where, following the application of Article 4, it has not been possible to trace the exact Belgian holdings of origin and where analyses of the products for dioxins or PCBs have not been carried out. L 175/74 EN Official Journal of the European Communities 10. 7. 1999 97/78/EC, are placed under restriction until their destruction by a means approved by the competent authority in a manner that ensures that they cannot enter the human food or animal feed chain. or until the results of analysis demonstrate that the products are not contaminated with dioxins or, that they do not exceed the levels for PCBs set out in Annex A. Belgium shall keep full records demonstrating compliance with this Article. Article 7 Commission inspections may be carried out in order to verify the implementation of this Decision. Article 8 Member States shall adopt the necessary measures to bring their trade rules into conformity with this Decision. They shall immediately inform the Commission thereof. Article 9 This Decision may be reviewed in the light of the results of Commission inspections and of information received by Member States. Article 10 Decision 1999/363/EC and Decision 1999/389/EC are repealed. Article 11 This Decision is addressed to the Member States. Done at Brussels, 9 July 1999. For the Commission Emma BONINO Member of the Commission Paragraph 1 shall apply only if the following conditions 2. are fulfilled: (a) Belgium must have authorised in writing the return of the product indicating the exact address of the establishment to which the products must be returned (b) the product must be accompanied by an official certificate as laid down in Annex F to this Decision and by a copy of the commercial document or the health certificate which accompanied the product from Belgium to the Member State concerned; (c) the products must be transported in containers or vehicles sealed by the competent authority of the Member State concerned in such a manner that the seals will be broken whenever the container or the vehicle is opened; (d) the products must be conveyed directly to the establish- ment referred to in point(a); (e) Member States which return products to Belgium must inform by telefax the competent authority in charge of the establishment referred to in point (a), of the place of origin and of the place of destination of the returned product giving the details laid down in the Annex to Decision 91/637/EC (1). The words ‘Product returned in accordance with Article 5 of Decision 1999/449/EC' must be contained in the fax; (f) Belgium must send confirmation by fax of the arrival of the to the competent authority of each consignment Member State which returned the product; (g) Belgium must ensure that the returned product is placed under restriction until its destruction by a means approved by the competent authority in a manner that ensures that it cannot enter the human food or animal feed chain or until the results of analysis demonstrate that the product is not contaminated with dioxins or, that it does not exceed the levels in Annex A to Decision 1999/449/EC; for PCB set out Belgium shall keep full records demonstrating compliance 3. with paragraph 2. Article 6 Belgium shall ensure that the products of Belgian origin which are re-imported into Belgium from third countries in accord- ance with the conditions laid down in Article 15 of Directive (1) OJ L 343, 13. 12. 1991, p. 46. 10. 7. 1999 EN Official Journal of the European Communities L 175/75 ANNEX A Maximum levels for PCBs for certain products listed in Article 1(1) Products Maximum level PCBs (1) Eggs, egg products, fresh poultrymeat and derived products Raw milk, heat-treated milk and milk based products (1) Sum of the following PCBs (IUPAC): 28, 52, 101, 118, 138, 153, 180. 200 ng/g fat 100 ng/g fat L 175/76 EN Official Journal of the European Communities 10. 7. 1999 ANNEX B HEALTH CERTIFICATE for products intended for human or animal consumption of Belgian origin derived from domestic fowl, bovine animals and pigs listed in Article 1(1)(A) of Decision 1999/449/EC Country of destination: Reference number of this health certificate:. Responsible ministry (1): — Minist(cid:138)re des affaires sociales, de la sant(cid:138) publique et de l’environnement, — Minist(cid:138)re des classes moyennes et de l’agriculture. Cetrifying department:. I. Identification of the products (1): — fresh meat, as defined by Council Directive 64/433/EEC, — fresh poultrymeat, as defined by Council Directive 71/118/EEC, — mechanically recovered meat, — minced meat and meat preparation, as defined by Council Directive 94/65/EC, — meat products and other products of animal origin as defined by Council Directive 77/99/EEC, — products intended for human consumption which contain other products of bovine, porcine or poultry origin as defined by Directive 77/99/EEC, which contain more that 2 % of animal fat, with the exclusion of milk fat, — eggs, — egg products, as defined by Council Directive 89/437/EEC, with the exclusion of egg white; — products intended for human consumption which contain more than 2 % of eggs or more than 2 % of egg products containing more than 10 % of egg fat, — rendered fats, as referred to by Council Directive 92/118/EEC, — processed animal proteins, as referred to by Directive 92/118/EEC, — raw material for the manufacture of animal feedingstuffs, as referred to by Directive 92/118/EEC, — compound feedingstuffs and pre-mixtures. The products was derived from: domestic fowl/bovine animals/pigs (1) Nature of packaging:. Number of cuts or packages:. Net weight:. II. Origin of the products Address and veterinary approval or registration No of the approved or registered establishment:. (1) Delete as appropriate. 10. 7. 1999 EN Official Journal of the European Communities L 175/77 III. Destination of the products The product will be sent from:. (place of loading) To:. (country and place of destination) By the following means of transport:. Name and address of consignor:. Name and address of consignee:. IV. Attestation I, the undersigned official competent authority, declare that I am aware of the provisions laid down in Decision 1999/449/EC and certify that the product described above is in compliance with Decision 1999/449/EC and, in particular, that (1): — the product is not deived from animals reared in holdings under restriction by the Belgian authorities, or — the result of analysis demonstrate that the product is not contaminated with dioxins or, that it does not exceed the levels for certain PCBs set out in Annex A of Decision 1999/449/EC. Done at. , on. (place) (date) Stamp (2). (signature of the official competent authority) (2). (name in capital letters, qualification and title) (1) Delete as appropriate. (2) The signature and the stamp must be in a colour different to that of the printing. L 175/78 EN Official Journal of the European Communities 10. 7. 1999 ANNEX C OFFICIAL DECLARATION For domestic fowl and hatching eggs referred to in Article 1(3) of Decision 1999/449/EC Health certificate number:. Number of the declaration:. DECLARATION I, the undersigned official veterinarian, declare that I am aware of the provisions laid down in Decision 1999/449/EC and certifiy that the animals/hatching eggs (1) accompanied by the attached health certificate are in compliance with Decision 1999/449/EC and, in particular, that the animals have not been reared in holdings under restriction by the Belgian authorities/the hatching eggs have not been derived from animals reared in holdings under restriction by the Belgian authorities (1) Done at. , on. (place) (date) Stamp (2). (signature of the official veterinarian of Minist(cid:138)re des classes moyennes et de l’agriculture) (2). (name in capital letters, qualification and title) (1) Delete as appropriate. (2) The signature and the stamp must be in a colour different to that of the printing. 10. 7. 1999 EN Official Journal of the European Communities L 175/79 ANNEX D OFFICIAL DECLARATION For bovine animals and pigs listed in Article 1(3) of Decision 1999/449/EC Health certificate number:. Number of the Declaration:. DECLARATION I, the undersigned official veterinarian, declare that I am aware of the provisions laid down in Decision 1999/449/EC and certify that the bovine animals/pigs (1) accompanied by the attached health certificate are in compliance with Decision 1999/449/EC and, in particular, that the animals have not been reared in holdings under restriction by the Belgian authorities. Done at. , on. (place) (date) Stamp (2). (signature of the official veterinarian of Minist(cid:138)re des classes moyennes et de l’Agriculture) (2). (name in capital letters, qualification and title) (1) Delete as appropriate. (2) The signature and the stamp must be in a colour different to that of the printing. L 175/80 EN Official Journal of the European Communities 10. 7. 1999 ANNEX E OFFICIAL DECLARATION For live animals, hatching eggs and products of Belgian origin covered by Article 1(1)(A) and Article 1(3) which were dispatched from Belgium before 12 June 1999 Responsible ministry (1): — Minist(cid:138)re des affaires sociales, de la sant(cid:138) publique et de l’environnement, — Minist(cid:138)re des classes moyennes et de l’agriculture. Certifying department:. Number of the declaration:. DECLARATION I, the undersigned official competent authority, declare that I am aware of the provisions laid down in Decision 1999/449/EC and certify that (1): — the domestic fowl/bovine animals/pigs (1) which were sent from Belgium to. (2), on. (3) and which were accompanied by the attached health certificate are in compliance with Decision 1999/449/EC and, in particular, that the animals have not been reared in holdings under restriction by the Belgian authorities, — hatching eggs which were sent from Belgium to. (2), on. (3) and which were accompanied by the attached health certificate are in compliance with Decision 1999/449/EC and, in particular, that the hatching eggs have not been derived from animals reared in holdings under restriction by the Belgian authorities, — the following product. (4), which were sent from Belgium to. (2) on. (3) and which were accompanied by the attached commercial document/health certificate No. have not been derived from animals reared in holdings under restriction by the Belgian authorities. Done at. , on. (place) (date) Stamp (5). (signature of the official competent authority) (5). (name in capital letters, qualification and title) (1) Delete as appropriate. (2) Place of destination. (3) Date of dispatching. (4) Description of the product. (2) The signature and the stamp must be in a colour different to that of the printing. 10. 7. 1999 EN Official Journal of the European Communities L 175/81 ANNEX F HEATH CERTIFICATE For products of Belgian origin covered by Decision 1999/449/EC intended to be returned to Belgium from Member States Country of destination: BELGIUM Reference number of this health certificate:. Responsible ministry:. Certifying department:. I. Identification of the products (1): — fresh meat, as defined by Council Directive 164/433/EEC, — fresh poultrymeat, as defined by Council Directive 71/118/EEC, — mechanically recovered meat, — minced meat and meat preparation, as defined by Council Directive 94/65/EC, — meat products and other products of animal origin as defined by Council Directive 77/99/EEC, — products intended for human consumption which contain other products of bovine, porcine or poultry origin as defined by Council Directive 77/99/EEC, which contain more that 2 % of animal fat, with the exclusion of milk fat, — eggs, — egg products, as defined by Council Directive 89/437/EEC, with the exclusion of egg white, — products intended for human consumption which contain more than 2 % of eggs or more than 2 % of egg products containing more that 10 % of egg fat, — rendered fats, as referred to by Council Directive 92/118/EEC, — processed animal proteins, as referred to by Directive 92/118/EEC, — raw material for the manufacture of animal feedingstuffs, as referred to by Directive 92/118/EEC, — compound feedingstuffs and pre-mixtures. The product was derived from: domestic fowl/bovine animals/pigs (1). Nature of packaging:. Number of cuts or packages:. Net weight:. II. Origin of the products Address and veterinary approval or registration number of the Belgian approved or registered establishment (2). :. III. Destination of the products The product will be sent from:. (address of the place of loading) To:. (address of the place of destination) By the following means of transport:. (1) Delete as appropriate. (2) If applicable. L 175/82 EN Official Journal of the European Communities 10. 7. 1999 Number of the official seal:. Name and address of consignor:. Name and address of consignee:. IV. Attestation I, the undersigned official competent authority, certify: (a) that a declaration has been received from the consignee/holder/retailer (1) of the product described above stating that the product was consigned from Belgium accompanied by the commercial document certificate (1) No. a copy of which is attached to the present certificate; (b) that the product is being returned to Belgium in conformity with Article 5 of Decision 1999/449/EC, and, in particular: — the product has not been analysed for dioxins or PCBs, and — in all other respects the product still retains the same sanitary status which it had on arrival. Done at. (place) , on. (date) Stamp (2). (signature of the official competent authority) (2). (name in capital letters, qualification and title) (1) If applicable. (2) The signature and the stamp must be in colour different to that of the printing


title: 1999/493/CE, CECA, Euratom: Décision du Conseil du 9 juillet 1999 relative à la composition de la Commission

eurovoc_concepts:
European Commission
European Commissioner

text: 24. 7. 1999 FR Journal officiel des Communaut(cid:130)s europ(cid:130)ennes L 192/53 D(cid:144)CISION DU CONSEIL du 9 juillet 1999 relative (cid:133) la composition de la Commission (1999/493/CE, CECA, Euratom) LE CONSEIL DE L’UNION EUROP(cid:144)ENNE, vu le trait(cid:130) instituant la Communaut(cid:130) europ(cid:130)enne, et notam- ment son article 215, vu le trait(cid:130) instituant la Communaut(cid:130) europ(cid:130)enne du charbon et de l’acier, et notamment son article 12, vu le trait(cid:130) instituant la Communaut(cid:130) europ(cid:130)enne de l’(cid:130)nergie atomique, et notamment son article 128, consid(cid:130)rant ce qui suit: (1) (2) (3) (4) (5) par lettre en date du 16 mars 1999, le pr(cid:130)sident de la Commission des Communaut(cid:130)s europ(cid:130)ennes, M. Jacques Santer, a inform(cid:130) M. Gerhard Schr(cid:148)der, pr(cid:130)sident de la conf(cid:130)rence des repr(cid:130)sentants des gouvernements des (cid:144)tats membres de l’Union europ(cid:130)enne, de la d(cid:130)cision des membres de la Commission de d(cid:130)missionner collective- ment et de remettre leur mandat entre les mains des gouvernements des (cid:144)tats membres; dans leur lettre de d(cid:130)mission, le pr(cid:130)sident et les membres de la Commission ont d(cid:130)clar(cid:130), en application de l’article 215, quatri(cid:138)me alin(cid:130)a, du trait(cid:130) instituant la Commu- naut(cid:130) europ(cid:130)enne et des articles correspondants du trait(cid:130) instituant la Communaut(cid:130) europ(cid:130)enne du charbon et de l’acier (CECA) et du trait(cid:130) instituant la Communaut(cid:130) europ(cid:130)enne de l’(cid:130)nergie atomique (CEEA) qu’ils assume- ront leurs fonctions jusqu’(cid:133) ce qu’il soit pourvu (cid:133) leur remplacement selon les proc(cid:130)dures pr(cid:130)vues par les trait(cid:130)s; par d(cid:130)claration en date du 22 mars 1999, le Conseil, tout en estimant n(cid:130)cessaire de nommer une nouvelle Commission le plus rapidement possible et dans le respect des proc(cid:130)dures pr(cid:130)vues par le trait(cid:130) d’Ams- terdam, a souhait(cid:130) que la Commission continue d’ici l(cid:133) (cid:133) assumer ses fonctions conform(cid:130)ment aux trait(cid:130)s; par lettre en date du 29 juin 1999, M. Martin Bange- mann, membre de la Commission, a inform(cid:130) M. Gerhard Schr(cid:148)der, pr(cid:130)sident de la conf(cid:130)rence des repr(cid:130)sentants des gouvernements des (cid:144)tats membres, de son intention de ne plus assumer ses fonctions au sein de la Commis- sion et d’exercer une activit(cid:130) professionnelle dans une entreprise; par lettres en date du 6 juillet 1999, M. Jacques Santer, pr(cid:130)sident de la Commission et Mme Emma Bonino, membre de cette Commision, ont inform(cid:130) M. Paavo Lipponen, pr(cid:130)sident de la conf(cid:130)rence des repr(cid:130)sentants des gouvernements des (cid:144)tats membres, de leur (cid:130)lection en qualit(cid:130) de membre du Parlement europ(cid:130)en; compte tenu de l’incompatibilit(cid:130) des qualit(cid:130)s de membre du Parlement europ(cid:130)en et de membre de la Commission, M. Santer et Mme Bonino ont l’intention d’opter en faveur de leur mandat parlementaire, et souhaitent que la proc(cid:130)- dure pr(cid:130)vue (cid:133) l’article 215 du trait(cid:130) aboutisse au plus tard pour le 19 juillet 1999, veille de la r(cid:130)union consti- tutive du Parlement europ(cid:130)en; aux termes de l’article 215, troisi(cid:138)me alin(cid:130)a, du trait(cid:130) et des articles correspondants des trait(cid:130)s CECA et CEEA, en le pr(cid:130)sident de la Commission est cas de d(cid:130)mission, remplac(cid:130) pour la dur(cid:130)e du mandat restant (cid:133) courir, la proc(cid:130)dure applicable pour son remplacement (cid:130)tant celle qui est pr(cid:130)vue (cid:133) l’article 214, paragraphe 2, du trait(cid:130); aux termes du quatri(cid:138)me alin(cid:130)a dudit article, sauf en cas les membres de la Commission de d(cid:130)mission d’office, restent en fonction jusqu’(cid:133) ce qu’il soit pourvu (cid:133) leur remplacement; aux termes du deuxi(cid:138)me alin(cid:130)a de ce m(cid:136)me article, le Conseil, statuant (cid:133) l’unanimit(cid:130), peut d(cid:130)cider qu’il n’y a pas lieu (cid:133) remplacement d’un commis- saire dont les fonctions prennent fin; apr(cid:138)s la d(cid:130)mission susvis(cid:130)e en date du 16 mars 1999, la proc(cid:130)dure pr(cid:130)vue (cid:133) l’article 214, paragraphe 2, du trait(cid:130), pour la nomination du pr(cid:130)sident et des membres de la future Commission, a (cid:130)t(cid:130) imm(cid:130)diatement entam(cid:130)e; r(cid:130)unis (cid:133) Berlin les 24 et 25 mars 1999, les chefs d’(cid:144)tat ou de gouvernement des (cid:144)tats membres ont d(cid:130)sign(cid:130) d’un commun accord M. Romano Prodi en tant que personnalit(cid:130) qu’ils envisagent de nommer pr(cid:130)sident de la Commission; la proc(cid:130)dure de nomination du pr(cid:130)sident et des membres de la Commission qui remplaceront le pr(cid:130)sident et les membres actuellement d(cid:130)missionnaires est en cours et doit aboutir dans le courant du mois de septembre 1999; dans ces circonstances et compte tenu de ce qui pr(cid:130)c(cid:138)de, il y a lieu, d’une part, de prendre acte des demandes de M. Santer, de M. Bangemann et de Mme Bonino, de ne plus continuer (cid:133) assumer leurs fonctions (cid:133) la Commis- sion et, d’autre part, de d(cid:130)cider qu’il n’y a pas lieu de proc(cid:130)der (cid:133) leur remplacement dans l’attente de la nomi- nation de la nouvelle Commission, (6) (7) (8) D(cid:144)CIDE: Article premier Il est pris acte des demandes de M. Jacques Santer, de M. Martin Bangemann et de Mme Emma Bonino d’(cid:136)tre relev(cid:130)s de leurs fonctions (cid:133) la Commission des Communaut(cid:130)s europ(cid:130)ennes. Il n’y a pas lieu de proc(cid:130)der (cid:133) leur remplacement. L 192/54 FR Journal officiel des Communaut(cid:130)s europ(cid:130)ennes 24. 7. 1999 Article 2 La pr(cid:130)sente d(cid:130)cision prend effet le jour de son adoption en ce qui concerne M. Bangemann et le 19 juillet 1999 en ce qui concerne M. Santer et Mme Bonino. Elle sera communiqu(cid:130)e (cid:133) M. Santer, (cid:133) M. Bangemann et (cid:133) Mme Bonino ainsi qu’aux gouvernements des (cid:144)tats membres de l’Union europ(cid:130)enne. La pr(cid:130)sente d(cid:130)cision est publi(cid:130)e au Journal officiel des Communaut(cid:130)s europ(cid:130)ennes. Article 3 Fait (cid:133) Bruxelles, le 9 juillet 1999. Par le Conseil Le pr(cid:130)sident S. NIINIST(cid:153)


title: 99/520/EG: Beschikking van de Commissie van 9 juli 1999 tot wijziging van Beschikking 98/589/EG betreffende de verlenging van de maximumtermijn voor de aanbrenging van oormerken bij bepaalde runderen van de Spaanse veestapel (kennisgeving geschied onder nummer C(1999) 2039) (Voor de EER relevante tekst)

text: L 199/72 NL Publicatieblad van de Europese Gemeenschappen 30. 7. 1999 COMMISSIE BESCHIKKING VAN DE COMMISSIE van 9 juli 1999 tot w¶ziging van Beschikking 98/589/EG betreffende de verlenging van de maximumterm¶n voor de aanbrenging van oormerken b¶ bepaalde runderen van de Spaanse veestapel (kennisgeving geschied onder nummer C(1999) 2039) (Voor de EER relevante tekst) (1999/520/EG) DE COMMISSIE VAN DE EUROPESE GEMEENSCHAPPEN, (4) Gelet op het Verdrag tot oprichting van de Europese Gemeen- schap, Overwegende dat de in deze beschikking vervatte maat- regelen in overeenstemming zĳn met het advies van het Comité van het Europees Oriëntatie- en Garantiefonds voor de Landbouw, HEEFT DE VOLGENDE BESCHIKKING GEGEVEN: Artikel 1 In de bĳlage bĳ Beschikking 98/598/EG wordt bĳ de provincie „Palencia” in de kolom „Comarca” de vermelding van de districten „El Cerrato, Campos, Saldaña — Valdavia” vervangen door „Toda la provincia”. Deze beschikking is gericht tot de lidstaten. Artikel 2 Gedaan te Brussel, 9 juli 1999. Voor de Commissie Franz FISCHLER Lid van de Commissie Gelet op Verordening (EG) nr. 820/97 van de Raad van 21 april 1997 tot vaststelling van een identificatie- en registratiere- geling voor runderen en inzake de etikettering van rundvlees en rundvleesproducten (1), inzonderheid op artikel 4, lid 2, Gezien het door Spanje ingediende verzoek, (1) (2) (3) Overwegende dat bĳ Beschikking 98/589/EG van de Commissie (2) voor Spanje wegens praktische moeilĳk- heden de maximumtermĳn voor de aanbrenging van oormerken bĳ bepaalde runderen met zes maanden is verlengd; Overwegende dat, op grond van een verzoek van de Spaanse autoriteiten, de bĳlage bĳ deze beschikking gewĳzigd moet worden zodat voortaan de gehele provincie Palencia vermeld wordt in plaats van de drie districten („Comarcas”) die oorspronkelĳk in de bĳlage bĳ Beschikking 98/589/EG waren aangegeven; Overwegende dat deze wĳziging gerechtvaardigd is omdat alle in de genoemde provincie geboren runderen aan de voorwaarden van die beschikking voldoen; (1) PB L 117 van 7. 5. 1997, blz. 1. (2) PB L 283 van 21. 10. 1998, blz. 19


title: Verordnung (EG) Nr. 1505/1999 der Kommission vom 9. Juli 1999 betreffend die Erteilung von Einfuhrlizenzen für frisches, gekühltes oder gefrorenes hochwertiges Rindfleisch

eurovoc_concepts:
beef
fresh meat
frozen product
import licence
product quality
refrigerated product

formats: pdf print

text: L 175/6 DE Amtsblatt der Europ(cid:132)ischen Gemeinschaften 10. 7. 1999 VERORDNUNG (EG) Nr. 1505/1999 DER KOMMISSION vom 9. Juli 1999 betreffend die Erteilung von Einfuhrlizenzen f(cid:129)r frisches, gek(cid:129)hltes oder gefrorenes hochwertiges Rindfleisch DIE KOMMISSION DER EUROP(cid:142)ISCHEN GEMEINSCHAFTEN — (3) gest(cid:129)tzt auf den Vertrag zur Gr(cid:129)ndung der Europ(cid:132)ischen Gemeinschaft, gest(cid:129)tzt auf die Verordnung (EG) Nr. 936/97 der Kommission vom 27. Mai 1997 zur Er(cid:148)ffnung und Verwaltung von Zoll- kontingenten f(cid:129)r hochwertiges frisches, gek(cid:129)hltes oder gefro- renes Rindfleisch und gefrorenes B(cid:129)ffelfleisch (1), zuletzt ge(cid:132)n- dert durch die Verordnung (EG) Nr. 134/1999 (2), in Erw(cid:132)gung nachstehender Gr(cid:129)nde: (1) (2) Die Verordnung (EG) Nr. 936/97 sieht in den Artikeln 4 und 5 die Bedingungen f(cid:129)r Antr(cid:132)ge auf und die Erteilung von Einfuhrlizenzen f(cid:129)r das in Artikel 2 Buchstabe f) genannte Fleisch vor. Die Verordnung (EG) Nr. 936/97 hat in Artikel 2 Buch- stabe f) die Menge frischen, gek(cid:129)hlten oder gefrorenen hochwertigen Rindfleischs mit Ursprung in und Herkunft aus den Vereinigten Staaten von Amerika und Kanada, die im Zeitraum vom 1. Juli 1999 bis zum 30. Juni 2000 unter besonderen Bedingungen eingef(cid:129)hrt werden kann, auf 11 500 t festgesetzt. Es ist darauf hinzuweisen, daß die in dieser Verordnung vorgesehenen Lizenzen w(cid:132)hrend ihrer gesamten G(cid:129)ltig- keitsdauer nur unter Ber(cid:129)cksichtigung der tierseuchen- rechtlichen Regelungen verwendet werden k(cid:148)nnen — HAT FOLGENDE VERORDNUNG ERLASSEN: Artikel 1 Jedem vom 1. bis 5. Juli 1999 eingereichten Einfuhrli- (1) zenzantrag f(cid:129)r frisches, gek(cid:129)hltes oder gefrorenes hochwertiges Rindfleisch gem(cid:132)ß Artikel 2 Buchstabe f) der Verordnung (EG) Nr. 936/97 wird vollst(cid:132)ndig stattgegeben. Antr(cid:132)ge auf Lizenzen k(cid:148)nnen gem(cid:132)ß Artikel 5 der (2) Verordnung (EG) Nr. 936/97 in den ersten f(cid:129)nf Tagen des Monats August 1999 f(cid:129)r 1 532,167 t gestellt werden. Artikel 2 Diese Verordnung tritt am 10. Juli 1999 in Kraft. Diese Verordnung ist in allen ihren Teilen verbindlich und gilt unmittelbar in jedem Mitglied- staat. Br(cid:129)ssel, den 9. Juli 1999 F(cid:129)r die Kommission Franz FISCHLER Mitglied der Kommission (1) ABl. L 137 vom 28. 5. 1997, S. 10. (2) ABl. L 17 vom 22. 1. 1999, S. 22


title: Kommissionens förordning (EG) nr 1506/1999 av den 9 juli 1999 om ändring av bilaga I till rådets förordning (EEG) nr 2658/87 om tulltaxe- och statistiknomenklaturen och om Gemensamma tulltaxan

eurovoc_concepts:
common customs tariff
pharmaceutical product
tariff exemption
tariff nomenclature

text: 10. 7. 1999 SV Europeiska gemenskapernas officiella tidning L 175/7 KOMMISSIONENS F(cid:153)RORDNING (EG) nr 1506/1999 av den 9 juli 1999 om (cid:132)ndring av bilaga I till r(cid:134)dets f(cid:148)rordning (EEG) nr 2658/87 om tulltaxe- och statistiknomenkla- turen och om Gemensamma tulltaxan EUROPEISKA GEMENSKAPERNAS KOMMISSION HAR ANTAGIT DENNA F(cid:153)RORDNING med beaktande av F(cid:148)rdraget om uppr(cid:132)ttandet av Europeiska gemenskapen, med beaktande av r(cid:134)dets f(cid:148)rordning (EEG) nr 2658/87 av den 23 juli 1987 om tulltaxe- och statistiknomenklaturen och om Gemensamma tulltaxan (1), senast (cid:132)ndrad genom kommissio- nens f(cid:148)rordning (EG) nr 1372/1999 (2), s(cid:132)rskilt artikel 9 i denna, och av f(cid:148)ljande sk(cid:132)l: Till f(cid:148)ljd av f(cid:148)rhandlingarna inom Uruguayrundan har befrielse fr(cid:134)n tullar beviljats f(cid:148)r vissa farmaceutiska (cid:132)mnen. En andra (cid:148)versyn av (cid:148)verenskommelserna om dessa produkter har (cid:132)gt rum inom V(cid:132)rldshandelsorgani- sationen (WTO). I r(cid:134)dets f(cid:148)rordning (EG) nr 1110/1999 (3) f(cid:148)reskrivs f(cid:148)lj- aktligen att import av vissa aktiva best(cid:134)ndsdelar med ”internationella generiska ben(cid:132)mningar” (INN), som fast- st(cid:132)llts av V(cid:132)rldsh(cid:132)lsoorganisationen (WHO), och av vissa mellanprodukter framst(cid:132)llning av f(cid:132)rdiga farmaceutiska produkter skall vara befriad fr(cid:134)n tullar. som anv(cid:132)nds f(cid:148)r H(cid:142)RIGENOM F(cid:153)RESKRIVS F(cid:153)LJANDE. Artikel 1 Texten i ”C. Farmaceutiska produkter” i avsnitt II (S(cid:132)rskilda best(cid:132)mmelser) i del 1 i bilaga I till kommissionens f(cid:148)rordning (EG) nr 2261/98 (4) skall ers(cid:132)ttas med texten i bilaga A till den h(cid:132)r f(cid:148)rordningen. Artikel 2 Avdelning II i del 3, bilaga I till f(cid:148)rordning (EG) nr 2261/98 skall (cid:132)ndras p(cid:134) f(cid:148)ljande s(cid:132)tt: 1. Produkterna i bilaga B till den h(cid:132)r f(cid:148)rordningen skall l(cid:132)ggas till i bilaga 3 (INN). 2. Produkterna i bilaga C till den h(cid:132)r f(cid:148)rordningen skall l(cid:132)ggas till i bilaga 4 (prefix och suffix). 3. Produkterna i bilaga D till den h(cid:132)r f(cid:148)rordningen skall l(cid:132)ggas till i bilaga 6 (farmaceutiska mellanprodukter). Artikel 3 (cid:142)ndringarna b(cid:148)r inf(cid:148)rlivas med bilaga I till f(cid:148)rordning (EEG) nr 2658/87. De (cid:134)tg(cid:132)rder som f(cid:148)reskrivs i denna f(cid:148)rordning (cid:132)r f(cid:148)ren- liga med tullkodexkommitt(cid:130)ns yttrande. Denna f(cid:148)rordning tr(cid:132)der i kraft den tredje dagen efter det att den har offentliggjorts i Europeiska gemenskapernas officiella tidning. Den skall till(cid:132)mpas fr(cid:134)n och med den 1 juli 1999. Denna f(cid:148)rordning (cid:132)r till alla delar bindande och direkt till(cid:132)mplig i alla medlemsstater. Utf(cid:132)rdad i Bryssel den 9 juli 1999. P(cid:134) kommissionens v(cid:132)gnar Mario MONTI Ledamot av kommissionen 1. 2. 3. 4. (1) EGT L 256, 7. 9. 1987, s. 1. (2) EGT L 162, 26. 6. 1999, s. 46. (3) EGT L 135, 29. 5. 1999, s. 1. (4) EGT L 292, 30. 10. 1998, s. 1. L 175/8 SV Europeiska gemenskapernas officiella tidning 10. 7. 1999 BILAGA A ”C. Farmaceutiska produkter 1. Tullbefrielse g(cid:132)ller f(cid:148)r farmaceutiska produkter av f(cid:148)ljande kategorier: i) De farmaceutiska (cid:132)mnen som omfattas av CAS RN (Chemical Abstracts Service Registry Numbers) och de internationella generiska ben(cid:132)mningar (INN) som f(cid:148)rtecknas i bilaga 3. ii) De salter, estrar eller hydrater av INN som betecknas genom en kombination av INN i bilaga 3 och prefix eller suffix i bilaga 4, under f(cid:148)ruts(cid:132)ttning att dessa produkter kan klassificeras enligt samma sexsiffriga HS-nummer som motsvarande INN. iii) De salter, estrar eller hydrater av INN som f(cid:148)rtecknas i bilaga 5 och inte kan klassificeras enligt samma sexsiffriga HS-nummer som motsvarande INN. iv) De farmaceutiska mellanprodukter som f(cid:148)rtecknas i bilaga 6, identifierbara genom ett kemiskt namn och ett CAS RN, och som anv(cid:132)nds f(cid:148)r framst(cid:132)llning av f(cid:132)rdiga farmaceutiska produkter. 2. S(cid:132)rskilda fall: i) INN omfattar endast de (cid:132)mnen vilka (cid:132)r upptagna i f(cid:148)rteckningen (cid:148)ver rekommenderade och f(cid:148)reslagna INN som publiceras av V(cid:132)rldsh(cid:132)lsoorganisationen (WHO). N(cid:132)r antalet (cid:132)mnen som omfattas av INN (cid:132)r f(cid:132)rre (cid:132)n de som omfattas av CAS RN, kan endast de (cid:132)mnen som omfattas av INN komma i fr(cid:134)ga f(cid:148)r tullbefrielse. ii) N(cid:132)r en produkt i bilaga 3 eller 6 identifieras med hj(cid:132)lp av ett CAS RN som motsvarar en specifik isomer, kan endast denna isomer beviljas tullbefrielse. iii) De dubbelderivat (salter, estrar eller hydrater) av INN, som betecknas genom en kombination av INN i bilaga 3 och prefix eller suffix i bilaga 4 omfattas av tullbefrielsen, under f(cid:148)ruts(cid:132)ttning att dessa produkter kan klassificeras enligt samma sexsiffriga HS-nummer som motsvarande INN. exempel: alaninmetylester, hydroklorid iv) Om en INN i bilaga 3 (cid:132)r ett salt (eller en ester) omfattas inget annat salt (ingen annan ester) av den syra som motsvarar den INN det g(cid:132)ller av tullbefrielse. exempel: oxprenoatkalium (INN): tullfri oxprenoatnatrium: inte tullfri” 10. 7. 1999 SV Europeiska gemenskapernas officiella tidning L 175/9 F(cid:153)RTECKNING (cid:153)VER DE INTERNATIONELLA GENERISKA BEN(cid:142)MNINGAR (INN) SOM SKALL L(cid:142)GGAS TILL I F(cid:153)RTECKNINGAR (cid:153)VER TULLFRIA PRODUKTER I BILAGA 3 TILL F(cid:153)RORDNING (EG) nr 2261/98 BILAGA B KN-nr CAS RN Namn KN-nr CAS RN Namn 2844 40 30 74855-17-7 iokanlidsyra (123 I) 2930 90 16 13189-98-5 fudostein 155798-07-5 iometopan (123 I) 136794-86-0 joflupan (123 I) 94153-50-1 mespiperon (11 C) 154427-83-5 samarium (153 Sm) lexidronam 178959-14-3 teknetium (99m Tc) apcitid 165942-79-0 157476-76-1 teknetium (99m Tc) nofetu- momab merpentan teknetium (99m Tc) pintu- momab 2906 19 00 131918-61-1 parikalcitol 134404-52-7 seokalcitol 2914 40 90 38398-32-2 ganaxolon 2918 30 00 69956-77-0 pelubiprofen 2922 19 90 82186-77-4 lumefantrin 129612-87-9 miproxifen 173324-94-2 temiverin 2922 49 70 148553-50-8 pregabalin 2922 50 00 141993-70-6 eldacimib 34391-04-3 levosalbutamol 134865-33-1 meluadrin 2924 10 00 146919-78-0 opratonjodid 138531-07-4 sinapultid 2924 21 90 159910-86-8 droxinavir 2924 29 90 138112-76-2 agomelatin 891-60-1 deklopramid 175385-62-3 lasinavir 105816-04-4 nateglinid 78281-72-8 nepafenak 172820-23-4 pexiganan 150812-12-7 retigabin 123441-03-2 rivastigmin 2925 19 80 162706-37-8 elinafid 129688-50-2 minalrestat 2925 20 00 146978-48-5 moxilubant 17035-90-4 targinin 160677-67-8 tresperimus 149820-74-6 xemilofiban 2926 90 99 123548-56-1 akreozast 2928 00 90 141184-34-1 filaminast 95268-62-5 upenazim 2930 90 70 129453-61-8 fulvestrant 159138-80-4 137109-78-5 kariporid orazipon 2932 19 00 142996-66-5 furomin 2932 29 80 107724-20-9 eplerenon 2932 99 70 61136-12-7 135038-57-2 almurtid fasidotril 2932 99 80 169758-66-1 robalzotan 2933 19 90 142155-43-9 cizolirtin 2933 21 00 177563-40-5 karafiban 2933 29 90 40077-57-4 aviptadil 170851-70-4 ipamorelin 173997-05-2 nepikastat 2933 39 95 173997-05-2 nepikastat 183552-38-7 abarelix 154229-19-3 abirateron 125602-71-3 bepotastin 159997-94-1 birikodar 171655-91-7 brasofensin 145599-86-6 cerivastatin 120958-90-9 dalkotidin 120014-06-4 donepezil 83799-24-0 fexofenadin 145216-43-9 forasartan 166432-28-6 klevidipin 170566-84-4 lanepitant 159776-68-8 linetastin 145414-12-6 lirexaprid 171049-14-2 lotrafiban 141725-10-2 milakainid 139886-32-1 milamelin 155418-06-7 nolpitantbesilat 160492-56-8 osanetant 157716-52-4 103922-33-4 perifosin pibutidin 156137-99-4 rapacuronbromid 149926-91-0 revatropat 162401-32-3 roflumilast 158876-82-5 rupatadin 159912-53-5 sabkomelin 142001-63-6 saredutant 172927-65-0 sibrafiban 140944-31-6 silperison 149979-74-8 terbogrel 154413-61-3 tikolubant 135354-02-8 xaliproden L 175/10 SV Europeiska gemenskapernas officiella tidning 10. 7. 1999 KN-nr CAS RN Namn KN-nr CAS RN Namn 2933 40 10 151096-09-2 moxifloxacin 154612-39-2 palinavir 127254-12-0 sitafloxacin 2933 40 90 143664-11-3 elakridar 139314-01-5 kilostigmin 159989-64-7 nelfinavir 2933 59 70 136470-78-5 abakavir 135637-46-6 atizoram 156862-51-0 belaperidon 132810-10-7 blonanserin 59989-18-3 eniluracil 164150-99-6 fandofloxacin 167933-07-5 flibanserin 160738-57-8 gatifloxacin 150378-17-9 indinavir 141549-75-9 indisetron 130018-77-8 levocetirizin 130636-43-0 nifekalant 147149-76-6 nolatrexed 152939-42-9 opanixil 133432-71-0 peldesin 137281-23-3 pemetrexed 130800-90-7 sipatrigin 148408-65-5 sunepitron 103300-74-9 taltirelin 175865-60-8 valganciklovir 116308-55-5 vatanidipin 2933 79 00 129722-12-9 aripiprazol 164656-23-9 dutasterid 156001-18-2 embusartan 129300-27-2 fabesetron 110958-19-5 fasoracetam 134143-28-5 glaspimod 155974-00-8 ivabradin 149503-79-7 lefradafiban 163250-90-6 orbofiban 133737-32-3 pagoklon 135729-56-5 palonosetron 2933 90 60 150408-73-4 pranazepid 137332-54-8 tivirapin 2933 90 95 157182-32-6 alatrofloxacin 153205-46-0 asimadolin 123018-47-3 atiprimod 135779-82-7 bamakimast 121104-96-9 celgosivir 159776-69-9 cemadotin 153438-49-4 dapitant 140661-97-8 deltibant 162301-05-5 ecenofloxacin 143322-58-1 eletriptan 158747-02-5 frovatriptan 153436-22-7 gavestinel 157476-77-2 lagatid 153504-81-5 likostinel 159776-70-2 melagatran 127657-42-5 minodronsyra 145375-43-5 mitiglinid 122332-18-7 mivobulin 156601-79-5 nepaprazol 114856-44-9 oberadilol 158364-59-1 pumaprazol 144034-80-0 rizatriptan 169312-27-0 talviralin 94948-59-1 tasonermin 2934 10 00 153242-02-5 aseripid 136468-36-5 foropafant 136381-85-6 lintitript 155213-67-5 ritonavir 122320-73-4 rosiglitazon 2934 30 90 135003-30-4 apadolin 2934 90 96 122384-88-7 amlintid 108912-17-0 atliprofen 154355-76-7 atreleuton 135928-30-2 beloxepin 153507-46-1 bibapcitid 107233-08-9 cevimelin 118976-38-8 dabelotin 143249-88-1 dexefaroxan 154598-52-4 efavirenz 155773-59-4 ensakulin 165800-04-4 eperezolid 148031-34-9 eptifibatid 136087-85-9 fidarestat 144245-52-3 fomivirsen 68134-81-6 gacyklidin 145508-78-7 ikopezil 117279-73-9 israpafant 111974-69-7 ketiapin 163252-36-6 klevudin 133242-30-5 landiolol 113457-05-9 ledoxantron 165800-03-3 linezolid 110143-10-7 lodenosin 164178-54-5 mazokalim 148564-47-0 milfasartan 10. 7. 1999 SV Europeiska gemenskapernas officiella tidning L 175/11 KN-nr CAS RN Namn KN-nr CAS RN Namn 121032-29-9 nelzarabin 183747-35-5 nepadutant 167305-00-2 omapatrilat 176894-09-0 omiloxetin 153168-05-9 plekonaril 151126-32-8 pramlintid 179474-81-8 prukaloprid 112887-68-0 raltitrexed 135459-90-4 ranelsyra 170902-47-3 roxifiban 143248-63-9 sinitrodil 145574-90-9 skopinast 130403-08-6 soretolid 131987-54-7 tazomelin 110221-53-9 temokaprilat 147650-57-5 tererstigmin 159098-79-0 tilnoprofenarbamel 131094-16-1 trafermin 148998-94-1 trekovirsen 141575-50-0 vedaklidin 107452-89-1 zikonotid 139264-17-8 zolmitriptan 2935 00 90 154323-57-6 almotriptan 151140-96-4 avitriptan 138890-62-7 brinzolamid 30236-32-9 dexsotalol 141626-36-0 dronedaron 159634-47-6 ibutamoren 138384-68-6 metesind 140695-21-2 osutidin 129981-36-8 sampatrilat 139755-83-2 sildenafil 127373-66-4 sivelestat 2937 10 00 150490-84-9 follitropin beta 177073-44-8 koriogonadotropin alfa 2937 22 00 123013-22-9 amelometason 2937 29 00 76675-97-3 resokortol 2937 99 00 140703-49-7 avorelin 182212-66-4 avotermin 165101-51-9 bekaplermin 157238-32-9 cetermin 116094-23-6 insulin aspart 160337-95-1 insulin glargin 158861-67-7 pralmorelin 146706-68-5 rismorelin 2938 90 90 150332-35-7 pamakesid 2939 50 00 136145-07-8 arofyllin 2939 90 90 149882-10-0 lurtotekan 162652-95-1 vinflunin 2940 00 90 132682-98-5 glufosfamid 2941 10 90 151287-22-8 tobicillin 2941 90 00 129639-79-8 abafungin 135821-54-4 ceftizoxime alapivoxil 129791-92-0 rifalazil 101312-92-9 valnemulin 121584-18-7 valspodar 3002 10 118390-30-0 interferon alfakon-1 3002 10 91 154361-48-5 arcitumomab 179045-86-4 basiliximab 158318-63-9 bektumomab 156586-90-2 cedelizumab 156586-89-9 edrekolomab 169802-84-0 enlimomab pegol 167816-91-3 faralimomab 167747-20-8 felvizumab 171656-50-1 igovomab 170277-31-3 infliximab 174722-30-6 keliximab 182912-58-9 klenoliximab 166089-32-3 lintuzumab 162774-06-3 nerelimomab 174722-31-7 rituximab 167747-19-5 sulesomab 180288-69-1 trastuzumab 3002 10 95 161753-30-6 daniplestim 142298-00-8 emoktakin 142261-03-8 hemoglobin krosfumaril 154248-96-1 iroplact 137463-76-4 milodistim 166089-33-4 nagrestipen 113478-33-4 nonakog alfa 145941-26-0 oprelvekin 112721-39-8 pifonakin 148883-56-1 tifakogin 3003 20 00 123760-07-6 zinostatinstimalamer 3507 90 90 151912-42-4 pamiteplas 99821-47-3 urokinas alfa 3907 20 99 186638-10-8 pegmusirudin 3911 90 99 182815-43-6 kolesevelam 52757-95-6 sevelamer 3913 90 80 83513-48-8 danaparoidnatrium L 175/12 SV Europeiska gemenskapernas officiella tidning 10. 7. 1999 BILAGA C F(cid:153)RTECKNING (cid:153)VER DE PREFIX OCH SOM I BILAGA 4 TILL F(cid:153)R(cid:153)RORDNING (EG) NR 2261/98 SKALL L(cid:142)GGAS TILL I F(cid:153)RTECKNINGEN (cid:153)VER DE PREFIX OCH SUFFIX SOM KOMBINERADE MED DE INTERNA- TIONELLA GENERISKA BEN(cid:142)MNINGARNA I BILAGA 3 BESKRIVER DE SENARES SALTER, ESTRAR ELLER HYDRATER BENSOAT DIFUMARAT DIPIVOXIL MONOBENSOAT TETRAISOPROPYL 10. 7. 1999 SV Europeiska gemenskapernas officiella tidning L 175/13 BILAGA D F(cid:153)RTECKNINGAR (cid:153)VER DE FARMACEUTISKA MELLANPRODUKTER (DVS. SAMMANS(cid:142)TTNINGAR SOM ANV(cid:142)NDS F(cid:153)R FRAMST(cid:142)LLNING AV F(cid:142)RDIGA FARMACEUTISKA PRODUKTER) SOM SKALL L(cid:142)GGAS TILL I F(cid:153)RTECKNINGEN (cid:153)VER TULLFRIA PRODUKTER I BILAGA 6 TILL F(cid:153)RORDNING (EG) nr 2261/98 KN-nr CAS RN Namn 2844 40 30 82407-94-1 1-[4-(2-dimetylaminoetoxi) [14C]fenyl)]-1,2-difenylbutan-1-ol 2903 59 90 7051-34-5 bromometylcyklopropan 2904 90 85 4714-32-3 1-nitro-4-(1,2,2,2-tetrakloroetyl)bensen 2905 22 90 1113-21-9 (6E,10E,14E)-3,7,11,15-tetrametylhexadeka-1,6,10,14-tetraen-3-ol 7212-44-4 3,7,11-trimetyldodeka-1,6,10-trien-3-ol 2905 29 90 2914-69-4 (S)-but-3-yn-2-ol 2905 49 10 1947-62-2 (2R,3R)-1,4-bis(mesyloxi)butan-2,3-diol 2905 50 20 148043-73-6 4,4,5,5,5-pentafluoropentan-1-ol 75-89-8 2,2,2-trifluoroetanol 2905 50 99 57090-45-6 (R)-3-kloropropan-1,2-diol 2907 19 00 27673-48-9 5,8-dihydro-1-naftol 2909 30 90 3383-72-0 (2-kloroetyl) (4-nitrofenyl)eter 2910 30 00 51594-55-9 (R)-1-kloro-2,3-epoxipropan 2910 90 00 129940-50-7 (S)-[(trityloxi)metyl]oxiran 2912 49 00 1620-98-0 3,5-di-tert-butyl-4-hydroxibensaldehyd 2144-08-3 2,3,4-trihydroxibensaldehyd 2914 50 00 28315-93-7 5-hydroxi-1,2,3,4-tetrahydro-1-nafton 104-20-1 4-(4-metoxifenyl)butan-2-on 1078-19-9 6-metoxi-1,2,3,4-tetrahydro-1-nafton 2914 70 90 150587-07-8 21-bensyloxi-9-alfa-fluoro-11-beta,17-alfa-dihydroxi-16-alfa-metylpregna-1,4-dien-3,20-dion 153977-22-1 trans-2-kloro-3-[4-(4-klorofenyl)cyklohexyl]-1,4-naftokinon 151265-34-8 21-kloro-16-alfa-metylpregna-1,4,9(11)-trien-3,20-dion 534-07-6 1,3-dikloroaceton 2915 39 90 24085-06-1 2-acetoxi-5-acetylbensylacetat 37413-91-5 3,20-dioxopregna-1,4,9(11),16-tetraen-21-ylacetat 7753-60-8 17-alfa-hydroxi-3,20-dioxopregna-4,9(11)-dien-21-ylacetat 2915 90 80 18997-19-8 klorometylpivalat 2916 20 00 3721-95-7 cyklobutankarboxylsyra 2916 31 00 132294-17-8 (1S,2S,3S)-2,3-bis(bensoyloximetyl)cyklobutanol 132294-16-7 (2S,3S)-2,3-bis(bensoyloxymetyl)cyklobutanon 2916 39 00 141109-25-3 2-bromo-2-(2-klorofenyl)(cid:132)ttiksyra 119916-27-7 4,6-dibromo-3-fluoro-o-tolylsyra 55332-37-1 (S)-2-(4-fluorofenyl)-3-metylsm(cid:148)rsyra 2417-72-3 Metyl 4-(bromometyl)bensoat 4276-85-1 2-(2,4,6-triisopropylfenyl)(cid:132)ttiksyra 2917 19 90 6065-63-0 dietyldipropylmalonat 28868-76-0 dimetylkloromalonat 2918 19 99 157604-22-3 dinatrium-(2S,3R)-2-hydroxi-3-isobutylsuccinat 90315-82-5 etyl-(R)-4-fenyl-2-hydroxibutyrat 36394-75-9 (S)-alfa-kloroformyletylacetat L 175/14 SV Europeiska gemenskapernas officiella tidning 10. 7. 1999 KN-nr CAS RN Namn 2918 29 90 168899-58-9 3-acetoxi-o-tolylsyra 3943-89-3 etyl-3,4-dihydroxibensoat 2918 30 00 302-97-6 3-oxoandrost-4-en-17-beta-karboxylsyra 2918 90 90 157283-68-6 isopropyl-(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxi-2-{(E)-(3R)-3-hydroxi-4-[3-(trifluorometyl)fenoxi]but- 1-enyl}cyklopentyl]hept-5-enoat 70264-94-7 metyl 4-(bromometyl)-m-anisat 33924-48-0 metyl-5-kloro-o-anisat 2920 90 10 208338-09-4 (4R,5R)-4,5-bis(mesyloximetyl)-1,3,2-dioxatiolan-2,2-dioxid 35180-01-9 isopropylklorometylkarbonat 16606-55-6 (R)-propylenkarbonat 2921 19 80 5407-04-5 3-kloropropyldimetylammoniumklorid 2921 29 00 100-36-7 2-aminoetyldietylamin 156886-85-0 N,NY-bis[3-(etylamino)propyl]propan-1,3-diamintetrahydroklorid 2921 30 10 167944-94-7 cyklohexylammonium-1-[(S)-2-(tert-butoxikarbonyl)-3-(2- metoxietoxi)propyl]cyklopentankarboxylat 2921 43 00 393-11-3 alfa,alfa,alfa-trifluoro-4-nitro-m-toluidin 2921 49 10 328-93-8 alfa,alfa,alfa,alfaY,alfaY,alfaY-hexafluoro-2,5-xylidin 2921 49 90 132173-07-0 (Z)-N-[3-(4-cyklohexyl-3-klorofenyl)prop-2-enyl]-N-etylcyklohexylaminhydroklorid 69385-30-4 2,6-difluorobensylamin 129140-12-1 1-etyl-1,4-difenylbut-3-enylamin 166943-39-1 metyl(4Y-nitrofenetyl)aminhydroklorid 33881-72-0 trietylanilin 81972-27-2 3-(triklorovinyl)anilinhydroklorid 2922 19 90 151851-75-1 (R)-2-amino-2-etylhexan-1-ol 154598-58-0 (S)-2-(2-amino-5-klorofenyl)-4-cyklopropyl-1,1,1-trifluorobut-3-yn-2-ol 534-03-2 2-aminopropan-1,3-diol 54527-65-0 2-[bensyl(metyl)amino]etylacetoacetat 151807-53-3 (1RS,2RS,3SR)-2,3-bis(bensoyloximetyl)cyklobutylamin 83647-29-4 3-{(Z)-1-[4-(2-dimetylaminoetoxi)fenyl]-2-fenylbut-1-enyl}fenol 1159-03-1 5-(3-dimetylaminopropyl)-10,11-dihydrodibenso[a,d]cyklohepten-5-ol 2922 30 00 2958-36-3 2-amino-2Y,5-diklorobensofenon 2922 49 70 128013-69-4 3-(aminometyl)-5-metylhexansyra 35453-19-1 5-amino-2,4,6-trijodoisoftalsyra 67299-45-0 cis-4-(bensyloxikarbonyl)cyklohexylammoniumtosylat 1118-89-4 dietyl-L-glutamathydroklorid 154772-45-9 etyl (S)-3-aminopent-4-ynoathydroklorid 961-69-3 kalium-(R)-N-(3-etoxi-1-metyl-3-oxoprop-1-enyl)-2-fenylglycin 119916-05-1 metyl-3-amino-4,6-dibromo-o-toluat 2922 50 00 35205-50-6 4Y-bensyloxi-2-[(1-metyl-2-fenoxietyl)amino]propiofenonhydroklorid 121524-09-2 etyl-((7S)-7-{[(2R)-2-hydroxi L-2-(3-klorofenyl)etyl]amino}-5,6,7,8-tetrahydro-2-naftyloxi) acetathydroklorid 16589-24-5 4-[1-hydroxi-2-(metylamino)etyl]fenol--L-vinsyra (2:1) 59338-84-0 metyl-4-amino-5-nitro-o-anisat 2924 10 00 90303-36-9 N-[N-(tert-butoxikarbonyl)-L-alanyl]-L-alaninhydrat 116833-20-6 2-(etylmetylamino)acetamid 10. 7. 1999 SV Europeiska gemenskapernas officiella tidning L 175/15 KN-nr CAS RN Namn 2924 29 90 112522-64-2 4-acetamido-2Y-aminobensanilid 24201-13-6 4-acetamido-5-kloro-o-anissyra 27313-65-1 N-acetyl-3-(3,4-dimetoxifenyl)-DL-alanin 40187-51-7 5-acetylsalicylamid 148051-08-5 5-amino-N,NY-bis[2-acetoxi-1-(acetoximetyl)etyl]-2,4,6-trijodoisoftalamid 76801-93-9 5-amino-N,NY-bis(2,3-dihydroxipropyl)-2,4,6-trijodoisoftalamid 41526-21-0 2Y-bensoyl-2-bromo-4-kloroacetanilid 91558-42-8 bensyl-(1-karbamoyl-2-hydroxipropyl)karbamat 1584-62-9 2-bromo-2Y-(2-fluorobensoyl)-4Y-kloroacetanilid 168960-18-7 tert-butyl-(1R,4S)-4-(hydroximetyl)cyklopent-2-enylkarbamat 50978-11-5 3,5-diacetamido-2,4,6-trijodobensoesyradihydrat 166518-60-1 N-[(2,6-diisopropylfenoxi)sulfonyl]-2-(2,4,6-triisopropylfenyl)acetamid 137246-21-0 N-(1-etyl-1,4-difenylbut-3-enyl)cyklopropankarboxamid 52806-53-8 2-hydroxi-2-metyl-4Y-nitro-3Y-(trifluorometyl)propionanilid 4093-29-2 metyl-4-acetamido-o-anisat 176972-62-6 metyl-(1S,2S)-1-bensyl-2-hydroxi-3-kloropropylkarbamat 153441-77-1 metyl-N-(fenoxikarbonyl)-L-valinat 41844-71-7 metyl-N-(metoxikarbonyl)-L-fenylalaninat 2925 19 80 1075-89-4 8-azaspiro[4. 5]dekan-7,9-dion 88784-33-2 1-bensylv(cid:132)te-(S)-4-ftalimidoglutarat 2925 20 00 149177-92-4 4Y-amidinosuccinanilsyrahydroklorid 2926 90 99 39186-58-8 4-bromo-2,2-difenylbutannitril 186038-82-4 dietyl (1-cyano-3-metylbutyl)malonat 15760-35-7 3-metylencyklobutankarbonitril 2928 00 90 192802-28-1 (S)-O-bensyllaktaldehyd-N-(tert-butoxikarbonyl)hydrazon 53016-31-2 13-etyl-17-alfa-hydroxi-18,19-dinorpregn-4-en-20-yn-3-onoxim 130580-02-8 trans-2Y-fluoro-4-hydroxichalkon-O-[(Z)-2-(dimetylamino)etyl]oxim--fumarsyra(2:1) 84080-70-6 4-kloro-2-[(Z)-(metoxikarbonyl)metoxiimino]-3-oxosm(cid:148)rsyra 55819-71-1 (RS)-serinohydrazidhydroklorid 2929 90 00 139976-34-4 NY-alfa-(tert-butoxikarbonyl)-N-metoxi-N-metyl-NY-omega-nitro-L-argininamid 2188-18-3 NY-alfa-(tert-butoxikarbonyl)-NY-omega-nitro-L-arginin 92050-02-7 2,6-diisopropylfenylsulfamat 2930 90 16 105996-54-1 N,NY-bis(trifluoroacetyl)-DL-homocystin 2930 90 70 157521-26-1 (S)-2-(acetyltio)-3-fenylpropionsyra--dicyklohexylamin (1:1) 148757-89-5 9-bromononyl-4,4,5,5,5-pentafluoropentylsulfid 182149-25-3 N,NY-[ditiobis(o-fenylenkarbonyl)]bis-L-isoleucin 33174-74-2 2,2Y-ditiodibensonitril 1134-94-7 2-(fenyltio)anilin 87483-29-2 4-fluorobensyl-4-(metyltio)fenylketon 6320-03-2 0-klorotiofenol 162515-68-6 2-[1-(merkaptometyl)cyklopropyl](cid:132)ttiksyra 4274-38-8 2-merkapto-5-(trifluorometyl)aniliniumklorid 62140-67-4 metyl-5-(etylsulfonyl)-o-anisat L 175/16 SV Europeiska gemenskapernas officiella tidning 10. 7. 1999 KN-nr CAS RN Namn 2931 00 95 31618-90-3 dietyl-(tosyloxi)metylfosfonat 17814-85-6 (4-karboxybutyl)trifenylfosfoniumbromid 1660-95-3 tetraisopropylmetylendifosfonat 2932 19 00 86087-23-2 (S)-tetrahydrofuran-3-ol 2932 29 80 23363-33-9 4Y-(bensyloxikarbonyl)-4Y-demetylepipodofyllotoxin 192704-56-6 11-alfa-hydroxi-7-alfa-(metoxikarbonyl)-3-oxopregn-4-en-21,17-alfa-karbolakton 73726-56-4 11-alfa-hydroxi-3-oxopregna-4,6-dien-21,17-alfa-karbolakton 2932 99 70 170242-34-9 (S)-2-amino-5-(1,3-dioxolan-4-yl)valeriansyra 57999-49-2 2-(3-bromofenoxi)tetrahydropyran 157518-70-2 (2R)-2-[(S)-2,2-dimetyl-5-oxo-1,3-dioxolan-4-yl]-4-metylvaleriansyra 114870-03-0 metyl-O-2-deoxi-6-O-sulfo-2-(sulfoamino)-alfa-D-glukopyranosyl-(1,4)-O-beta-D- glukopyranuronosyl-(1,4)-O-2-deoxi-3,6-di-O-sulfo-2-(sulfoamino)-alfa-D-glukopyranosyl- (1,4)-O-2-O-sulfo-alfa-L-2-(sulfoamino)-6-(hydrogensulfat)-alfa-D-glucopyranosid, decanatriumsalt 88128-61-4 (3aS,9aS,9bR)-3a-metyl-6-[2-(2,5,5-trimetyl-1,3-dioxan-2-yl)etyl]-1,2,4,5,8,9,9a,9b-oktahydro- 3aH-cyklopenta[a]naftalen-3,7-dion 2932 99 80 130525-62-1 (4S,5R,6R)-5-acetamido-4-amino-6-[(1R,2R)-1,2,3-trihydroxipropyl]-5,6-dihydropryran-2-karboxylsyra 107188-37-4 2-(4-aminofenoximetyl)-2,5,7,8-tetrametyl-4-oxokroman-6-ylacetat 69999-16-2 (2,3-dihydrobensofuran-5-yl)(cid:132)ttiksyra 107188-34-1 2,5,7,8-tetrametyl-2-(4-nitrofenoximetyl)-4-oxokroman-6-ylacetat 2933 19 90 139756-01-7 1-metyl-4-nitro-3-propylpyrazol-5-karboxamid 59194-35-3 NY1-metyl-1H-pyrazol-1-karboxamidinhydroklorid 4023-02-3 pyrazol-1-karboxamidinhydroklorid 2933 29 90 151012-31-6 3-(4-bromobensyl)-2-butyl-4-kloro-1H-imidazol-5-ylmetanol 151257-01-1 2-butyl-1,3-diazaspiro[4. 4]non-1-en-4-onhydroklorid 152146-59-3 4-(2-butyl-5-formylimidazo1-ylmetyl)bensoesyra 68282-49-5 2-butylimidazol-5-karbaldehyd 138401-24-8 4Y-[(2-butyl-4-oxo-1,3-diazaspiro[4. 4]non-1-en-3-yl)metyl]bifenyl-2-karbonitril 2933 39 95 176381-97-8 (S)-N-[4-(4-acetamido-4-fenyl-1-piperidyl)-2-(3,4-diklorofenyl)butyl]-N-metylbensamid- -fumarsyra (1:1) 171764-07-1 (S)-2-amino-3,3-dimetyl-N-2-pyridylbutyramid 180250-77-5 (2S,3S)-3-amino-2-etoxi-N-nitropiperidin-1-karboxamidinhydroklorid 65326-33-2 2-amino-3-pyridylmetylketon 142034-92-2 (1S,3S,4S)-1-azabicyklo[2. 2. 1]heptan-3-ol 21472-89-9 (+–)-1-azabicyklo[2. 2. 1]heptan-3-on 142034-97-7 (1R,4S)-1-azabicyklo[2. 2. 1]heptan-3-on 180050-34-4 (1S,4R)-1-azabicyklo[2. 2. 1]heptan-3-on-O-[(Z)-(3-metoxifenyl)etynyl]oxim--maleinsyra (1:1) 173050-51-6 (R)-N-(1-{3-[1-bensoyl-3-(3,4-diklorofenyl)-3-piperidyl]propyl}-4-fenyl-4-piperidyl)-N- metylacetamidhydroklorid 188591-61-9 1-(4-bensyloxifenyl)-2-(4-fenyl-4-hydroxi-1-piperidyl)propan-1-on 22065-85-6 1-bensylpiperidin-4-karbaldehyd 160588-45-4 10,10-bis[(2-fluoro-4-pyridyl)metyl]antron 10. 7. 1999 SV Europeiska gemenskapernas officiella tidning L 175/17 KN-nr CAS RN Namn 157688-46-5 2-[1-(tert-butoxikarbonyl)-4-piperidyl](cid:132)ttiksyra 56488-00-7 3-(cyanoimino)-3-piperidinopropionitril 193275-84-2 4-{4-[(11R)-3,10-dibromo-8-kloro-5,6-dihydro-11H-benso[5,6]cyklohepta[1,2-b] pyridin-11-yl]- piperidinokarbonylmetyl}piperidin-1-karboxamid 193275-85-3 4-{4-[(11S)-3,10-dibromo-8-kloro-5,6-dihydro-11H-benso[5,6]cykloheptal[1,2-b]pyridin-11-yl]- piperidinokarbonylmetyl}piperidin-1-karboxamid 153050-21-6 (S)-1-{2-[3-(3,4-diklorofenyl)-1-(3-isopropoxifenacil)-3-piperidyl]etyl}-4-fenyl-1- azoniabicyklo[2. 2. 2]oktanklorid 168273-06-1 1-(2,4-diklorofenyl)-5-(4-klorofenyl)-4-metyl-N-piperidino-1H-pyrazol-3-karboxamid 875-35-4 2,6-dikloro-4-metylnikotinonitril 35794-11-7 3,5-dimetylpiperidin 1452-94-4 etyl-2-kloronikotinat 49608-01-7 etyl-6-kloronikotinat 5223-06-3 2-(5-etyl-2-pyridyl)etanol 4783-86-2 4-fenoxipyridin 189894-57-3 4-fenyl-1-[(1S,2S)-2-hydroxi-2-(4-hydroxifenyl)-1-metyletyl]piperidin-4-olmethansulfonattrihydrat 179024-48-7 N-[(R)-1-fenyl-9-metyl-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]isonikotinamid 40807-61-2 4-fenylpiperidin-4-ol 5005-36-7 2-fenyl-2-pyridylacetonitril 5006-66-6 6-hydroxinikotinsyra 2008-75-5 1-(2-kloroetyl)piperidiniumklorid 5382-23-0 4-kloro-1-metylpiperidinhydroklorid 5326-23-8 6-kloronikotinsyra 100643-71-8 8-kloro-11-(4-piperidyliden)-5,6-dihydro-11H-benso[5,6]cyklohepta[1,2-b]pyridin 7379-35-3 4-kloropyridinhydroklorid 77145-61-0 1-(6-kloro-2-pyridyl)-4-piperidylaminhydroklorid 118175-10-3 [4-(3-metoxipropoxi)-3-metyl-2-pyridyl]metanol 103577-66-8 3-metyl-4-(2,2,2-trifluoroetoxi)-2-pyridylmetanol 5435-54-1 3-nitro-4-pyridon 6622-91-9 4-pyridyl(cid:132)ttiksyrahydroklorid 192329-80-9 4-(4-pyridyloxi)bensensulfonsyra 192330-49-7 4-(4-pyridyloxi)bensensulfonylkloridhydroklorid 2933 40 10 119916-34-6 7-bromo-1-cyklopropyl-6-fluoro-5-metyl-4-oxo-1,4-dihydrokinolin-3-karboxylsyra 136465-98-0 N-(2-kinolylkarbonyl)-L-asparagin 170143-39-2 3-metylv(cid:132)te-7-kloro-1,4-dihydro-4-oxokinolin-2,3-dikarboxylat 2933 40 90 136522-17-3 (3S,4aS,8aS)-2-[(2R,3S)-3-amino-4-fenyl-2-hydroxibutyl]-N-tert-butyldekahydroisokinolin- 3-karboxamid 149057-17-0 (S)-N-tert-butyl-1,2,3,4-tetrahydroisokinolin-3-karboxamidhydroklorid 186537-30-4 (S)-N-tert-butyl-1,2,3,4-tetrahydroisokinolin-3-karboxamidsulfat 146362-70-1 2-{[5-(2,6-dimetoxifenyl)-1-(7-kloro-4-kinolyl)-1H-pyrazol-3-yl]karbonylamino}adamantan-2- karboxylsyra 178680-13-2 metyl-{(1S,2R)-1-bensyl-3-[(3S,4aS,8aS)-3-(tert-butylkarbomoyl)dekahydro-2-isokinolyl]-2- hydroxipropyl}karbamat 181139-72-0 metyl-2-[(S)-3-hydroxi-3-{(E)-3-[2-(7-kloro-2-kinolyl)vinyl]fenyl}propyl]bensoat 149968-11-6 metyl-2-(3-{(E)-3-[2-(7-kloro-2-kinolyl)vinyl]fenyl}-3-oxopropyl)bensoat 74163-81-8 (S)-1,2,3,4-tetrahydroisokinolin-3-karboxylsyra L 175/18 SV Europeiska gemenskapernas officiella tidning 10. 7. 1999 KN-nr CAS RN Namn 2933 59 70 13889-98-0 1-acetylpiperazin 156126-53-3 (1R,2R,3S)-2-amino-9-[2,3-bis(bensoyloximetyl)cyklobutyl]-9H-purin-6-on 147149-89-1 2-amino-5-bromo-6-metylkinazolin-4(1H)-on 171887-03-9 N-(2-amino-4,6-dikloropyrimidin-5-yl)formamid 172015-79-1 [(1S,4R)-4-(2-amino-6-kloro-9H-purin-9-yl)cyklopent-2-enyl]metanolhydroklorid 707-99-3 6-amino-9H-purin-9-yletanol 14047-28-0 (R)-2-(6-animo-9H-purin-9-yl)-1-metyletanol 147127-20-6 (R)-[2-(6-amino-9H-purin-9-yl)-1-metyletoxi]metylfosfonsyrligsyra 149950-60-7 6-bensyl-1-(etoximetyl)-5-isopropylpyrimidin-2,4(1H,3H)-dion 156126-83-9 (1R,2R,3S)-9-[2,3-bis(bensoyloximetyl)cyklobutyl]-6-jodo-9H-purin-2-ylamin 202138-50-9 bis[(isopropyloxikarbonyloxi)metyl-[(R)-2-(6-amino-9H-purin-9-yl)-1-metyletoxi]metylfosfonat- -fumarsyra (1:1) 179688-29-0 6,7-bis(2-metoxietoxi)kinazolin-4(1H)-on 56-06-4 2,6-diaminopyrimidin-4-ol 188416-34-4 (2RS,3SR)-2-(2,4-difluorofenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol--(1R,4S)-2- oxobornan-10-sulfonsyra (1:1) 150728-13-5 4,6-dikloro-5-(2-metoxifenoxi)-2,2Y-bipyrimidinyl 153537-73-6 (S)-2-(4-{[(2,7-dimetyl-4-oxo-1,4-dihydrokinazolin-6-yl)metyl](prop-2-ynyl)amino}-2- fluorobensamido-4-(1H-tetrazol-5-yl)sm(cid:148)rsyra 7280-37-7 estropipat 112733-28-5 etyl-[3-(4-bromo-2-fluorobensyl)-7-kloro-2,4-dioxo-1,2,3,4-tetrahydrokinazolin-1-yl)]acetat 137234-87-8 6-etyl-5-fluoropyrimidin-4(1H)-on 183319-69-9 (3-etynylfenyl) [6,7-bis(2-metoxietoxi)kinazolin-4-yl]aminhydroklorid 184177-81-9 fenyl-{4-[-(4-hydroxifenyl)piperazin-1-yl]fenyl}karbamat 19690-23-4 6-jodo-1H-purin-2-ylamin 696-07-1 5-jodouracil 20535-83-5 6-metoxi-1H-purin-2-ylamin 65-71-4 5-metyluracil 20980-22-7 2-(piperazin-1-yl)pyrimidin 156126-48-6 tetrabutylammonium-(6-jodo-1H-purin-2-yl)amid 66-22-8 uracil 2933 79 00 175873-08-2 4-[(S)-3-amino-2-oxopyrrolidin-1-yl)bensonitrilhydroklorid 61865-48-3 (+–)-2-azabicyklo[2. 2. 1]hept-5-en-3-on 79200-56-9 (1R,4S)-2-azabicyklo[2. 2. 1]hept-5-en-3-on 159593-17-6 4-tert-butylbensyl-2-{(2R,3S)-3-[(R)-1-(tert-butyldimetylsilyloxi)etyl]-2- [(1R,3S)-3-metoxi-2-oxocyklohexyl]-4-oxoazetidin-1-yl}-2-oxoacetat 175873-10-6 etyl-3-(3-{(S)-1-[4-(NY2-hydroxiamidino)fenyl]-2-oxopyrrolidin-3-yl}ureido)propionat 139122-76-2 4-(2-fenyl-2-metylhydrazino)-5,6-dihydro-2-pyridon 56341-37-8 6-kloroindol-2(3H)-on 118289-55-7 6-kloro-5-(2-kloroetyl)indol-2(3H)-on 122852-75-9 5-metyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-on 90776-59-3 4-nitrobensyl-(4R,5R,6S)-3-(difenoxifosforyloxi)-6-[(R)-1-hydroxietyl]-4-metyl-7-oxo- 1-azabicyklo[3. 2. 0]hept-2-en-2-karboxylat 10. 7. 1999 SV Europeiska gemenskapernas officiella tidning L 175/19 KN-nr CAS RN Namn 2933 90 50 179528-39-3 N-(bifenyl-2-yl)-4-[(2-metyl-4,5-dihydro-1H-imidazo[4,5-d] [1]bensazepin-6-yl)karbonyl]bensamid 139592-99-7 (Z)-1-[3-(4-cyklohexyl-3-klorofenyl)prop-2-enyl]hexahydro-1H-azepinhydroklorid 2933 90 60 70890-50-5 3-amino-5-fenyl-7-metyl-1H-1,4-bensodiazepin-2(3H)-on 188978-02-1 (4R,5S,6S,7R)-1-[(3-amino-1H-indazol-5-yl)metyl]-4,7-dibensyl-3-butyl-5,6-dihydroxihexahydro- 2H-1,3-diazepin-2-on 106928-72-7 tert-butyl-(1S,9S)-9-ftalimido-6,10-dioxooktahydropyridazo[1,2-a] [1,2]diazepin-1-karboxylat 177932-89-7 (4R,5S,6S,7R)-4,7-dibensyl-1,3-bis(3-aminobensyl)-5,6-dihydroxihexahydro-2H-1,3-diazepin-2-ondimethansulfonat 2886-65-9 5-(2-fluorofenyl)-7-kloro-1H-1,4-bensodiazepin-2(3H)-on 2933 90 95 64137-52-6 [3-(1H-bensimidazol2-yl)propyl]metylamin 120851-71-0 trans-1-bensoyl-4-fenyl-L-prolin 151860-16-1 meso-3-bensyl-6-nitro-3-azabicyklo[3. 1. 0]hexan 65632-62-4 (S)-1-(bensyloxikarbonyl)hexahydropyriadazin-3-karboxylsyra 143322-57-0 5-bromo-3-[(R)-1-metylpyrrolidin-2-ylmetyl]indol 194602-25-0 dibensyl-1-(2,4-difluorfenyl)-2-(1H-1,2,4-triazol-1-yl)-1-(1H-1,2,4-triazol-1-ylmetyl)etylfosfat 137733-33-6 NY,NY-dietyl-N-(6-fenyl-5-propylpyridazin-3-yl)-2-metylpropan-1,2-diamin--fumarsyra (2:3) 71208-55-4 dietyl-(6-kloro-9H-karbazol-2-yl)metylmalonat 194602-27-2 difenyl[(S)-pyrrolidin-3-yl]acetonitrilhydrobromid 176161-55-0 (5,6-dikloro-1H-bensimidazo2-yl)isopropylamin 178619-89-1 6,7-dikloro-2,3-dimetoxikinoxalin-5-ylamin 153435-96-2 etyl-3-formyl-4,6-dikloroindol-2-karboxylat 185453-89-8 7-etyl-3-[2-(trimetylsilyloxi)etyl]indol 190791-29-8 (5R,6S)-6-fenyl-5-[4-(2-pyrrolidinoetoxi)fenyl]-5,6,7,8-tetrahydro-2-naftol--(-)-vinsyra (1:1) 2380-94-1 4-hydroxiindol 31251-41-9 8-kloro-5,6-dihydro-11H-benso[5,6]cyklohepta[1,2-b]pyridin-11-on 7250-67-1 N-(2-kloroetyl)pyrrolidinhydroklorid 170142-29-7 7-kloro-2-(4-metoxi-2-metylfenyl)-2,3-dihydro-5H-pyridazino[4,5-b]kinolin-1,4,10-trion, natriumsalt 182073-77-4 NY-[N-metoxikarbonyl-L-valyl]-N-[(S)-3,3,3-trifluoro-1-isopropyl-2-oxopropyl]-L-prolinamid 155322-92-2 (3R)-3-[(S)-1-(metylamino)etyl]pyrrolidin 127105-49-1 metyl-(S)-2-amino-4-(1H-tetrazol-5-yl)butyrat 132026-12-1 4-(2-metyl-1H-imidazo[4,5-c]pyridin-1-yl)bensoesyra 85440-79-5 2-metyl-1-nitrosoindolin 59032-27-8 natrium-1,2,3-triazol-5-tiolat 143722-25-2 2-(2-trityl-2H-tetrazol-5-yl)fenylboronsyra 2934 10 00 180144-61-0 3-{[4-(4-amidinofenyl)tiazol-2-yl] [1-(karboxymetyl)-4-piperidyl]amino}propionsyra 174761-17-2 Benshydryl 7-{(Z)-2-[2-tert-butoxikarbonylamino)tiazol-4-yl]-4-(3-metylbut-2-enyloxykarbonyl)but- 2-enamido}-3-cefem-4-karboxylat 190841-79-3 etyl-3-({4-[4-(N-etoxikarbonylamidino)fenyl]tiazol-2-yl} [1-(etoxikarbonylmetyl)-4- piperidyl]amino)propionat 556-90-1 2-imino-1,3-tiazol-4-on 105889-80-3 pivaloyloximetyl-7-{(Z)-2-[2-(tert-butoxikarbonylamino)tiazol-4-yl]pent-2-enamido}-3- (karbamoyloximetyl)-3-cefem-4-karboxylat 2295-31-0 tiazolidin-2,4-dion L 175/20 SV Europeiska gemenskapernas officiella tidning 10. 7. 1999 KN-nr CAS RN Namn 2934 20 80 89604-92-2 tert-butyl-2-{[1-(2-aminotiazol-4-yl)-2-(bensisotiazol-2-yltio)-2- oxoetyliden]aminooxi}-2-methylpropionat 177785-47-6 (2S,3S)-3-metyl-2-(3-oxo-2,3-dihydro-1,2-bensisotiazol-2-yl)valeriansyra 2934 90 96 143491-57-0 (2R,5S)-4-amino-5-fluoro-1-[2-(hydroximetyl)-1,3-oxatiolan5-yl]pyrimidin-2(1H)-on 80370-59-8 7-amino-3-(2-furoyltiometyl)-3-cefem-4-karboxylsyra 160115-08-2 {(E)-3-[(6R,7R)-7-amino-2-karboxylato-8-oxo-5-tia-1-azabicyklo[4. 2. 0]okt-2-en-3-yl]allyl} (karbamoylmetyl) (etyl)metylammonium 177575-17-6 (S)-N-{5-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-1H-pyrimido[5,4-b] [1,4]tiazin-6-yl)etyl}-2-tenoyl]- L-glutaminsyra 186521-45-9 (6S)-5-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b] [1,4]tiazin-6-yl)etyl]tiofen-2-karboxylsyra 116833-10-4 (Z)-2-(5-amino-1,2,4-tiadiazol-3-yl)-2-[(fluorometoxi)imino](cid:132)ttiksyra 38313-48-3 3Y,5Y-anhydrotymidin 3083-77-0 1-(beta-D-arabinofuranosyl)pyrimidin-2,4(1H,3H)-dion 108895-45-0 3Y-azido-2Y,3Y-dideoxi-5-metylcytidinhydroklorid 77887-68-4 benshydryl-6-(4-metylbensamido)penicillanat-4-oxid 157341-41-8 (2S)-N-[(R)-1-(1,3-bensodioxol-5-yl)butyl]-3,3-dietyl-2-{4-[(4-metylpiperazin-1-yl)karbonyl]fenoxi}-4- oxoazetidin-1-karboxamid 122567-97-9 5Y-bensoyl-2Y,3Y-didehydro-3Y-deoxitymidin 158512-24-4 (3aS,8aR)-3-[(2R,4S)-2-bensyl-4,5-epoxivaleryl]-2,2-dimetyl-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazol 168828-81-7 bensyl-(3-fluoro-4-morfolinofenyl)karbamat 14282-76-9 2-bromo-3-metyltiofen 63-37-6 cytidin-5Y-(div(cid:132)tefosfat) 145514-04-1 (2R,4R)-4-(2,6-diamino-9H-purin-9-yl)-1,3-dioxolan-2-ylmetanol 177932-89-7 (4R,5S,6S,7R)-4,7-dibensyl-1,3-bis(3-aminobensyl)-5,6-dihydroxihexahydro-2H-1,3-diazepin-2- ondimethansulfonat 177575-19-8 dietyl-N-{5-[2-((6S)-2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b] [1,4]tiazin-6-yl)etyl]- 2-tenoyl}-L-glutamat 181696-73-1 3,4-difenyl-5-metyl-4,5-dihydroisoxazol-5-ol 175712-02-4 [(3S,5S)-5-(2,4-difluorofenyl)-5-(1H-1,2,4-triazol-1-ylmetyl)tetrahydrofuran-3-yl]metyl-4-klorobensensulfonat 171228-49-2 4-[4-(4-{4-[(3R,5R)-5-(2,4-difluorofenyl)-5-(1H-1,2,4-triazol-1-ylmetyl)tetrahydrofuran-3- ylmetyloxi]fenyl}piperazin-1-yl)feny1]-1-[(1S,2S)-1-etyl-2-hydroxipropyl]-1,2,4-triazol-5(4H)-on 178357-37-4 (5aR,11bS)-9,10-dimetoxi-2-propyl-4,5,5a,6,7,11b-hexahydrobenso[f]tieno[2,3-c] kinolinhydroklorid 186521-41-5 dimetyl-2-[(S)-1-(tert-butoxikarbonylaminometyl)-2-(5-etoxikarbonyl-2-tienyl)propyltio]malonat 84915-43-5 (3S)-2,2-dimetyl-1,4-tiazinan-3-karboxylsyra 3206-73-3 DL-5-(1,2-ditiolan3-yl)valeramid 186521-40-4 etyl-5-[(3S)-3-(acetyltio)-4-(tert-butoxikarbonylamino)butyl]tiofen-2-karboxylat 208337-84-2 etyl-5-[(3R)-4-amino-3-hydroxibutyl]tiofen-2-karboxylat 186521-44-8 etyl-(6S)-5-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b] [1,4] tiazin-6-yl)etyl]tiofen-2-karboxylat 208337-82-0 etyl-5-(but-3-enyl)tiofen-2-karboxylat 186521-38-0 etyl-5-(3R)-4-(tert-butoxikarbonylamino)-3-hydroxibutyl]tiofen-2-karboxylat 186521-39-1 etyl-5-[(3R)-4-(tert-butoxikarbonylamino)-3-(mesyloxi)butyl]tiofen-2-karboxylat 208337-83-1 etyl-5-[(3R)-3,4-dihydroxibutyl]tiofen-2-karboxylat 10. 7. 1999 SV Europeiska gemenskapernas officiella tidning L 175/21 KN-nr CAS RN Namn 143468-96-6 etylv(cid:132)te(2-tienylmetyl)malonat 63877-96-3 2-(4-fluorobensyl)tiofen 184475-35-2 (4-fluoro-3-klorofenyl) [7-metoxi-6-(3-morfolinopropoxi)kinazolin-4-yl]amin 112984-60-8 (+–)-6-fluoro-1-metyl-4-oxo-7-(piperazin-1-yl)-4H-[1,3]tiazeto[3,2-a]kinolin-3-karboxylsyra 4691-65-0 inosin-5Y-dinatriumfosfat 167304-98-5 metyl-(4S,7S,10aS)-4-amino-5-oxooktahydro-7H-pyrido[2,1-b] [1,3]tiazepin-7-karboxylat 147086-83-7 N-[(4S,6S)-6-metyl-7,7-dioxo-5,6-dihydro-4H-tieno[2,3-b]tiopyran-4-yl]acetamid 186521-42-6 metyl-(S)-6-{2-[5-etoxikarbonyl)-2-tienyl]etyl}-3-oxo-1,4-tiazinan-2-karboxylat 59804-25-0 metyl-4-hydroxi-2-metyl-2H-tieno[2,3-e] [1,2]tiazin-3-karboxylat-1,1-dioxid 130209-90-4 metyl-2-(2-klorofenyl)-2-(4,5,6,7-tetrahydrotieno[3,2-c]pyridin-5-yl)acetathydroklorid 78850-37-0 metyl-(3aR,4R,7aR)-2-metyl-4-[(1S,2R)-1,2,3-triacetoxipropyl]-3a,7a-dihydro-4H-pyrano[3,4-d] oxazol-6-karboxylat 39925-10-5 metyl-1-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)-1H-1,2,4-triazol-3-karboxylat 1463-10-1 5-metyluridin 25954-21-6 5-metyluridinhemihydrat 28783-41-7 4,5,6,7-tetrahydrotieno[3,2-c]pyridinhydroklorid 50-89-5 tymidin 2935 00 90 183556-68-5 (S)-N-{(1S,2R)-3-[(1,3-bensodioxol-5-ylsulfonyl) (isobutyl)amino]-1-bensyl-2-hydroxipropyl}-3,3- dimetyl-2-(sarkosylamino)butyramid 6292-59-7 4-tert-butylbensensulfonamid 180200-68-4 4-(4-cyklohexyl-2-metyloxazol-5-yl)-2-fluorobensensulfonamid 150375-75-0 NY-{(2R,3S)-1-[(3,4-dimetoxifenyl)sulfonyl]-3-hydroxi-5-kloro-3-(2-klorofenyl)-2,3-dihydro-1H- indol-2-ylkarbonyl}-L-prolinamid 192329-83-2 (3S)-2,2-dimetyl-4-[4-(4-pyridyloxi)fenylsulfonyl]-1,4-tiazinan-3-karboxsylsyra 194602-23-8 2-etoxi-5-[(4-metylpiperazin-1-yl)sulfonyl]bensoesyra 181695-72-7 4-(3-fenyl-5-metylisoxazol-4-yl)bensensulfonamid 198470-85-8 N-[4-(3-fenyl-5-metylisoxazol-4-yl)fenylsulfonyl]propionamid,natriumsalt 179524-67-5 (S)-2-{3-[(2-fluorobensyl)sulfonylamino]-2-oxo-2,3-dihydro-1-pyridyl}-N-(1-formyl-4-guanidinobutyl) acetamid 17852-52-7 4-hydrazonobensensulfonamidhydroklorid 192329-42-3 (S)-N-hydroxi-2,2-dimetyl-4-[4-(4-pyridyloxi)fenylsulfonyl]-1,4-tiazinan-3-karboxamid 100632-57-3 4-[(4-mesylamino)fenyl]-4-oxosm(cid:148)rsyra 66644-80-2 3-metoxi-5-sulfamoyl-o-anissyra 147200-03-1 N-[(4S,6S)-6-metyl-7,7-dioxo-2-sulfamoyl-5,6-dihydro-4H-tieno[2,3-b]tiopyran-4-yl]acetamid 106820-63-7 metyl-3-[(metoxikarbonylmetyl)sulfamoyl]tiofen-2-karboxylat 33045-52-2 metyl-5-sulfamoyl-o-anisat 33288-71-0 5-metyl-N-[4-(sulfamoyl)fenetyl]pyrazin-2-karboxamid 161814-49-9 (3S)-tetrahydrofuran-3-yl-(1S,2R)-3-[(4-aminofenylsulfonyl) (isobutyl)amino]-1- bensyl-2-hydroxypropilkarbamat 169590-42-5 4-[5-(p-tolyl)-3-(triflurometyl)-1H-pyrazol-1-yl]bensensulfonamid L 175/22 SV Europeiska gemenskapernas officiella tidning 10. 7. 1999 KN-nr CAS RN Namn 2938 90 90 104443-57-4 1-O-[O-2-acetamido-2-deoxi-beta-D-galaktopyranosyl-(1,4)-O-(N-acetyl-alfa-neurami- nosyl)-(2,3)-O-beta-D-galaktopyranosyl-(1,4)-beta-D-glukopyranosyl]ceramid 196085-62-8 N-{[(1R,2R)-1-[O-(N-acetyl-alfa-neuraminosyl)-(2,3)-O-2-acetamido-2-deox(cid:146)-beta-D-galaktopyranosyl- (1,4)-O-beta-D-galaktopyranosyl-(1,4)-beta-D-glukopyranosylox(cid:146)metyl)-2-hydroxi-3- formylpropyl}stearamid 104443-62-1 1-O-[O-(N-acetyl-alfa-neuraminosyl)-(2,3)-O-[O-beta-D-galaktopyranosyl-(1,3)-2-acetamido-2- deoxi-beta-D-galaktopyranosyl-(1,4)]-O-beta-D-galaktopyranosyl-(1,4)]-beta-D-glukopyranosyl]ceramid 2939 10 00 41444-62-6 kodeinfosfathemihydrat 54417-53-7 (R)-1,2,3,4-tetrahydropapaverinhydroklorid 2939 90 90 51-55-8 92-13-7 atropin Pilokarpin 2940 00 90 182410-00-0 beta-cyklodextrinsulfobutyletrar, natriumsalter 24259-59-4 L-ribos 4132-28-9 2,3,4,6-tetra-O-bensyl-D-glukos 80312-55-6 2,3,4,6-tetra-O-bensyl-1-O-(trimetylsilyl)-beta-D-glukos 3002 10 95 116638-33-6 SC-59735 193700-51-5 SC-70935 195993-11-4 hemocyaniner, megathura crenulata, reaktionprodukter med 1-O-[0-2-acetamido-2-deoxi-beta-D- galaktopyranosyl-(1,4)-O-(N-acetyl-alfa-neuraminosyl)-(2,3)]-O-beta-D-galaktopyranosyl- (1,4)-beta-D-glukopyranos 3003 90 141256-04-4 1-(28-{O-D-apio-beta-D-furanosyl-(1,3)-O-beta-D-xylopyranosyl-(1,4)-O-6-deoxi-alfa-L- mannopyranosyl)-(1,2)-4-O-(5-alfa-L-arabinofuranosyloxi-3-hydroxi-6-metyloctanoyloxi)- 3-hydroxi-6-metyloctanoyl]-6-deoxi-beta-D-galaktopyranosyloxi}-16-alfa-hydroxi-23-beta,28- dioxoolean-12-en-3-beta-yl)-O-beta-D-galaktopyranosyl-(1,2)-O-beta-D-xylopyranosyl-(1,3)-beta-D- glukopyranosiduronsyra 195993-11,4 hemocyaniner, megathura crenulata, reaktionprodukter med 1-O-[O-2-acetamido-2-deoxi-beta-D- galaktopyranosyl-(1,4)-O-(N-acetyl-alfa-neuraminosyl)-(2,3)]-O-beta-D-galaktopyranosyl- (1,4)-beta-D-glukopyranos 3006 30 00 155773-56-1 Ferristen 3507 90 90 9002-12-4 uratoxidas


title: Verordening (EG) nr. 1514/1999 van de Commissie van 9 juli 1999 tot vaststelling, voor het verkoopseizoen 1999/2000, van de voor gedroogde pruimen (basisproduct) aan de telers te betalen minimumprijs en van het bedrag van de productiesteun voor pruimedanten

eurovoc_concepts:
dried product
marketing year
minimum price
production aid
stone fruit

text: L 175/38 NL Publicatieblad van de Europese Gemeenschappen 10. 7. 1999 VERORDENING (EG) Nr. 1514/1999 VAN DE COMMISSIE van 9 juli 1999 tot vaststelling, voor het verkoopseizoen 1999/2000, van de voor gedroogde pruimen (basispro- duct) aan de telers te betalen minimumpr¶s en van het bedrag van de productiesteun voor pruimedanten DE COMMISSIE VAN DE EUROPESE GEMEENSCHAPPEN, Gelet op het Verdrag tot oprichting van de Europese Gemeen- schap, Gelet op Verordening (EG) nr. 2201/96 van de Raad van 28 oktober 1996 houdende een gemeenschappelĳke ordening der markten in de sector van verwerkte producten op basis van groenten en fruit (1), gewĳzigd bĳ Verordening (EG) nr. 2199/ 97 (2), en met name op artikel 3, lid 3, en op artikel 4, lid 9, (1) (2) (3) Overwegende dat in artikel 2 van Verordening (EG) nr. 504/97 van de Commissie van 19 maart 1997 houdende uitvoeringsbepalingen van Verordening (EG) nr. 2201/96 van de Raad wat de productiesteunregeling voor verwerkte producten op basis van groenten en fruit betreft (3), laatstelĳk gewĳzigd bĳ Verordening (EG) nr. 702/1999 (4), de begin- en einddata van de verkoopsei- zoenen zĳn vastgesteld; Overwegende dat de criteria voor de vaststelling van de minimumprĳs en van de productiesteun respectievelĳk in artikel 3 en artikel 4 van Verordening (EG) nr. 2201/ 96 zĳn vastgesteld; Overwegende dat de producten waarvoor de minimum- prĳs en de steun worden vastgesteld, omschreven zĳn in artikel 3 van Verordening (EG) nr. 464/1999 van de Commissie van 3 maart 1999 houdende uitvoeringsbe- palingen van Verordening (EG) nr. 2201/96 van de Raad inzake de steunregeling voor pruimedanten (5) en dat de eisen waaraan de bedoelde producten moeten voldoen, zĳn vastgesteld in artikel 2 van voornoemde verorde- ning, zodat het dienstig is de minimumprĳs en de productiesteun voor het verkoopseizoen 1999/2000 vast te stellen; (4) Overwegende dat de in deze verordening vervatte maat- regelen in overeenstemming zĳn met het advies van het Comité van beheer voor op basis van groenten en fruit verwerkte producten, HEEFT DE VOLGENDE VERORDENING VASTGESTELD: Artikel 1 Voor het verkoopseizoen 1999/2000 bedraagt: a) de in artikel 3 van Verordening (EG) nr. 2201/96 bedoelde minimumprĳs voor gedroogde pruimen („prunes d'Ente”) 193,523 EUR per 100 kg nettogewicht af teler; b) de in artikel 4 van Verordening (EG) nr. 2201/96 bedoelde 79,976 EUR per pruimedanten productiesteun voor 100 kg nettogewicht. Artikel 2 Deze verordening treedt in werking op de derde dag volgende op die van haar bekendmaking in het Publicatieblad van de Europese Gemeenschappen. Deze verordening is verbindend in al haar onderdelen en is rechtstreeks toepasselĳk in elke lidstaat. Gedaan te Brussel, 9 juli 1999. Voor de Commissie Franz FISCHLER Lid van de Commissie (1) PB L 297 van 21. 11. 1996, blz. 29. (2) PB L 303 van 6. 11. 1997, blz. 1. (3) PB L 78 van 20. 3. 1997, blz. 14. (4) PB L 89 van 1. 4. 1999, blz. 26. (5) PB L 56 van 4. 3. 1999, blz. 8


title: Komission asetus (EY) N:o 1511/1999, annettu 9 päivänä heinäkuuta 1999, Kanariansaarten arvioidun hankintataseen vahvistamisesta neuvoston asetuksen (ETY) N:o 1601/92 2-5 artiklassa säädettyyn erityiseen järjestelmään kuuluvien viinialan tuotteiden osalta annetun asetuksen (EY) N:o 1261/96 muuttamisesta

eurovoc_concepts:
Canary Islands
aid system
supply balance sheet
viticulture

text: 10. 7. 1999 FI Euroopan yhteis(cid:148)jen virallinen lehti L 175/31 KOMISSION ASETUS (EY) N:o 1511/1999, annettu 9 p(cid:132)iv(cid:132)n(cid:132) hein(cid:132)kuuta 1999, Kanariansaarten arvioidun hankintataseen vahvistamisesta neuvoston asetuksen (ETY) N:o 1601/92 2—5 artiklassa s(cid:132)(cid:132)dettyyn erityiseen j(cid:132)rjestelm(cid:132)(cid:132)n kuuluvien viinialan tuotteiden osalta annetun asetuksen (EY) N:o 1261/96 muuttamisesta EUROOPAN YHTEIS(cid:153)JEN KOMISSIO, joka ottaa huomioon Euroopan yhteis(cid:148)n perustamissopimuksen, ottaa huomioon tiettyj(cid:132) maataloustuotteita koskevista erityis- toimenpiteist(cid:132) Kanariansaarten hyv(cid:132)ksi 15 p(cid:132)iv(cid:132)n(cid:132) kes(cid:132)kuuta 1992 annetun neuvoston asetuksen (ETY) N:o 1601/92 (1), sellaisena kuin se on viimeksi muutettuna asetuksella (EY) N:o 1257/1999 (2), ja erityisesti sen 2 artiklan, 3 artiklan 4 kohdan ja 4 artiklan 4 kohdan, sek(cid:132) katsoo, ett(cid:132) 1) 2) komission asetuksessa (EY) N:o 1261/96 (3), sellaisena kuin se on viimeksi muutettuna asetuksella (EY) N:o 1510/98 (4), saavien viinialan tuotteiden arvioidun hankintataseen m(cid:132)(cid:132)r(cid:132)t ajanjaksoksi 1 p(cid:132)iv(cid:132)st(cid:132) hein(cid:132)kuuta 1998 30 p(cid:132)iv(cid:132)(cid:132)n kes(cid:132)kuuta 1999, vahvistetaan yhteis(cid:148)n tukea olisi p(cid:132)(cid:132)tett(cid:132)v(cid:132) ajanjaksoksi 1 p(cid:132)iv(cid:132)st(cid:132) hein(cid:132)kuuta 1999 30 p(cid:132)iv(cid:132)(cid:132)n kes(cid:132)kuuta 2000 vahvistetut arvioidun hankintataseen m(cid:132)(cid:132)r(cid:132)t, jotta voidaan turvata hankinnan tuotanto-olot jatkuvuus Kanariansaarten erityiset huomioon ottaen; mainittujen viinialan tuotteiden hinnat yhteis(cid:148)ss(cid:132) ja maailmanmarkkinoilla huomioon ottaen olisi my(cid:148)s vahvistettava Kanariansaarten hankin- liitteess(cid:132) II olevien m(cid:132)(cid:132)rien mukaisesti, tatuki ja 3) t(cid:132)ss(cid:132) asetuksessa s(cid:132)(cid:132)detyt toimenpiteet ovat viinin hallin- tokomitean lausunnon mukaiset, ON ANTANUT T(cid:142)M(cid:142)N ASETUKSEN: 1 artikla Korvataan asetuksen (EY) N:o 1261/96, liitteet I ja II t(cid:132)m(cid:132)n asetuksen liitteill(cid:132) I ja II. 2 artikla T(cid:132)m(cid:132) asetus tulee voimaan kolmantena p(cid:132)iv(cid:132)n(cid:132) sen j(cid:132)lkeen, kun se on julkaistu Euroopan yhteis(cid:148)jen virallisessa lehdess(cid:132). Sit(cid:132) sovelletaan 1 p(cid:132)iv(cid:132)st(cid:132) hein(cid:132)kuuta 1999. T(cid:132)m(cid:132) asetus on kaikilta osiltaan velvoittava, ja sit(cid:132) sovelletaan sellaisenaan kaikissa j(cid:132)senval- tioissa. Tehty Brysseliss(cid:132) 9 p(cid:132)iv(cid:132)n(cid:132) hein(cid:132)kuuta 1999. Komission puolesta Franz FISCHLER Komission j(cid:132)sen (1) EYVL L 173, 27. 6. 1992, s. 13. (2) EYVL L 320, 11. 12. 1996, s. 1. (3) EYVL L 163, 2. 7. 1996, s. 15. (4) EYVL L 200, 16. 7. 1998, s. 13. L 175/32 FI Euroopan yhteis(cid:148)jen virallinen lehti 10. 7. 1999 LIITE I VIINIALAN TUOTTEET Kanariansaarten arvioitu hankintatase (1 p(cid:132)iv(cid:132)st(cid:132) hein(cid:132)kuuta 1999 30 p(cid:132)iv(cid:132)(cid:132)n kes(cid:132)kuuta 2000) CN-koodi Tuotteiden kuvaus M(cid:132)(cid:132)r(cid:132) (hehtolitroina) ex 2204 21 79 Viinit: ex 2204 21 80 ex 2204 21 83 ex 2204 21 84 — kolmansista maista per(cid:132)isin olevat viinit, esittelyss(cid:132) on alkuper(cid:132)ismaan nimi maantieteellist(cid:132) nimikett(cid:132) joiden kuvauksessa tai ilman muita merkint(cid:148)j(cid:132) tai 115 500 — yhteis(cid:148)st(cid:132) per(cid:132)isin olevat asetuksen (ETY) N:o 822/87 litteen I 13 kohdassa tarkoitetut p(cid:148)yt(cid:132)viinit ex 2204 29 62 Viinit: ex 2204 29 64 ex 2204 29 65 ex 2204 29 71 ex 2204 29 72 ex 2204 29 75 ex 2204 29 83 ex 2204 29 84 — kolmansista maista per(cid:132)isin olevat viinit, joiden kuvauksessa tai esittelyss(cid:132) on alkuper(cid:132)maan nimi ilman muita merkint(cid:148)j(cid:132) tai maan- tieteellist(cid:132) nimikett(cid:132) — yhteis(cid:148)st(cid:132) per(cid:132)isin olevat asetuksen (ETY) N:o 822/87 litteen I 13 kohdassa tarkoitetut p(cid:148)yt(cid:132)viinit 100 000 (1) (1) K(cid:132)ytet(cid:132)(cid:132)n joko kahden litran tai sit(cid:132) pienemmiss(cid:132) pulloissa tai teollista k(cid:132)ytt(cid:148)(cid:132) varten. Yhteens(cid:132) 215 500 10. 7. 1999 FI Euroopan yhteis(cid:148)jen virallinen lehti L 175/33 LIITE II Liitteess(cid:132) I tarkoitetuille tuotteille my(cid:148)nnetyt tuen m(cid:132)(cid:132)r(cid:132)t Tuotteiden koodi 2204 21 79 9120 2204 21 79 9220 2204 21 79 9180 2204 21 79 9280 2204 21 79 9910 2204 21 80 9180 2204 21 80 9280 2204 21 83 9120 2204 21 83 9180 2204 21 84 9180 2204 29 62 9120 2204 29 62 9220 2204 29 62 9180 2204 29 62 9280 2204 29 62 9910 2204 29 64 9120 2204 29 64 9220 2204 29 64 9180 2204 29 64 9280 2204 29 64 9910 2204 29 65 9120 2204 29 65 9220 2204 29 65 9180 2204 29 65 9280 2204 29 65 9910 2204 29 71 9180 2204 29 71 9280 2204 29 72 9180 2204 29 72 9280 2204 29 75 9180 2204 29 75 9280 2204 29 83 9120 2204 29 83 9180 2204 29 84 9180 (euroa/hl) Yhteis(cid:148)st(cid:132) tuleviin tuotteisiin sovellettavat tuen m(cid:132)(cid:132)r(cid:132)t 4,782 4,782 8,068 9,445 4,782 10,065 11,785 4,782 11,019 13,749 4,782 4,782 8,068 9,445 4,782 4,782 4,782 8,068 9,445 4,782 4,782 4,782 8,068 9,445 4,782 10,065 11,785 10,065 11,785 10,065 11,785 4,782 11,019 13,749